Project
Illumina Body Map 2: averaged replicates
Navigation
Downloads
Results for GATA3
Z-value: 3.35
Motif logo
Transcription factors associated with GATA3
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
GATA3
|
ENSG00000107485.11 | GATA binding protein 3 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| GATA3 | hg19_v2_chr10_+_8096631_8096660 | -0.13 | 4.8e-01 | Click! |
Activity profile of GATA3 motif
Sorted Z-values of GATA3 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr7_+_142498725 | 5.39 |
ENST00000466254.1
|
TRBC2
|
T cell receptor beta constant 2 |
| chr14_+_22694606 | 4.30 |
ENST00000390463.3
|
TRAV36DV7
|
T cell receptor alpha variable 36/delta variable 7 |
| chr1_+_26644441 | 3.67 |
ENST00000374213.2
|
CD52
|
CD52 molecule |
| chr2_-_89513402 | 3.65 |
ENST00000498435.1
|
IGKV1-27
|
immunoglobulin kappa variable 1-27 |
| chr14_+_22337014 | 3.40 |
ENST00000390436.2
|
TRAV13-1
|
T cell receptor alpha variable 13-1 |
| chr6_-_31560729 | 3.38 |
ENST00000340027.5
ENST00000376073.4 ENST00000376072.3 |
NCR3
|
natural cytotoxicity triggering receptor 3 |
| chr11_+_60223312 | 3.38 |
ENST00000532491.1
ENST00000532073.1 ENST00000534668.1 ENST00000528313.1 ENST00000533306.1 |
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1 |
| chr11_+_60223225 | 3.24 |
ENST00000524807.1
ENST00000345732.4 |
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1 |
| chr14_+_22931924 | 3.11 |
ENST00000390477.2
|
TRDC
|
T cell receptor delta constant |
| chr16_+_23847339 | 3.10 |
ENST00000303531.7
|
PRKCB
|
protein kinase C, beta |
| chr2_+_208527094 | 3.03 |
ENST00000429730.1
|
AC079767.4
|
AC079767.4 |
| chr2_+_90108504 | 3.00 |
ENST00000390271.2
|
IGKV6D-41
|
immunoglobulin kappa variable 6D-41 (non-functional) |
| chr3_+_108541545 | 2.88 |
ENST00000295756.6
|
TRAT1
|
T cell receptor associated transmembrane adaptor 1 |
| chr15_-_44969022 | 2.82 |
ENST00000560110.1
|
PATL2
|
protein associated with topoisomerase II homolog 2 (yeast) |
| chr16_+_23847355 | 2.79 |
ENST00000498058.1
|
PRKCB
|
protein kinase C, beta |
| chr4_+_78432907 | 2.73 |
ENST00000286758.4
|
CXCL13
|
chemokine (C-X-C motif) ligand 13 |
| chr2_-_89619904 | 2.68 |
ENST00000498574.1
|
IGKV1-39
|
immunoglobulin kappa variable 1-39 (gene/pseudogene) |
| chr16_+_23847267 | 2.56 |
ENST00000321728.7
|
PRKCB
|
protein kinase C, beta |
| chrX_-_70326455 | 2.48 |
ENST00000374251.5
|
CXorf65
|
chromosome X open reading frame 65 |
| chr22_+_22697537 | 2.48 |
ENST00000427632.2
|
IGLV9-49
|
immunoglobulin lambda variable 9-49 |
| chr2_+_89901292 | 2.46 |
ENST00000448155.2
|
IGKV1D-39
|
immunoglobulin kappa variable 1D-39 |
| chr15_-_20170354 | 2.42 |
ENST00000338912.5
|
IGHV1OR15-9
|
immunoglobulin heavy variable 1/OR15-9 (non-functional) |
| chrX_+_78426469 | 2.41 |
ENST00000276077.1
|
GPR174
|
G protein-coupled receptor 174 |
| chr17_+_72595971 | 2.33 |
ENST00000581412.1
|
CTD-2006K23.1
|
CTD-2006K23.1 |
| chr12_-_12837423 | 2.33 |
ENST00000540510.1
|
GPR19
|
G protein-coupled receptor 19 |
| chr18_-_68317947 | 2.32 |
ENST00000594039.1
ENST00000582578.1 |
GTSCR1
|
Gilles de la Tourette syndrome chromosome region, candidate 1 |
| chr7_+_142448053 | 2.31 |
ENST00000422143.2
|
TRBV29-1
|
T cell receptor beta variable 29-1 |
| chrX_+_128913906 | 2.30 |
ENST00000356892.3
|
SASH3
|
SAM and SH3 domain containing 3 |
| chr14_-_106494587 | 2.28 |
ENST00000390597.2
|
IGHV2-5
|
immunoglobulin heavy variable 2-5 |
| chr19_-_7764960 | 2.27 |
ENST00000593418.1
|
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23) |
| chr3_+_108541608 | 2.27 |
ENST00000426646.1
|
TRAT1
|
T cell receptor associated transmembrane adaptor 1 |
| chr2_-_158345462 | 2.26 |
ENST00000439355.1
ENST00000540637.1 |
CYTIP
|
cytohesin 1 interacting protein |
| chr1_+_159772121 | 2.26 |
ENST00000339348.5
ENST00000392235.3 ENST00000368106.3 |
FCRL6
|
Fc receptor-like 6 |
| chr14_-_106733624 | 2.25 |
ENST00000390610.2
|
IGHV1-24
|
immunoglobulin heavy variable 1-24 |
| chrX_+_70364667 | 2.24 |
ENST00000536169.1
ENST00000395855.2 ENST00000374051.3 ENST00000358741.3 |
NLGN3
|
neuroligin 3 |
| chr12_-_8088773 | 2.21 |
ENST00000544291.1
|
SLC2A3
|
solute carrier family 2 (facilitated glucose transporter), member 3 |
| chr7_+_142326335 | 2.21 |
ENST00000390393.3
|
TRBV19
|
T cell receptor beta variable 19 |
| chr7_-_142169013 | 2.18 |
ENST00000454561.2
|
TRBV5-4
|
T cell receptor beta variable 5-4 |
| chr3_-_128186091 | 2.17 |
ENST00000319153.3
|
DNAJB8
|
DnaJ (Hsp40) homolog, subfamily B, member 8 |
| chr14_-_25078864 | 2.15 |
ENST00000216338.4
ENST00000557220.2 ENST00000382548.4 |
GZMH
|
granzyme H (cathepsin G-like 2, protein h-CCPX) |
| chr19_+_5681153 | 2.14 |
ENST00000579559.1
ENST00000577222.1 |
HSD11B1L
RPL36
|
hydroxysteroid (11-beta) dehydrogenase 1-like ribosomal protein L36 |
| chr14_+_22180536 | 2.10 |
ENST00000390424.2
|
TRAV2
|
T cell receptor alpha variable 2 |
| chr13_-_47012325 | 2.09 |
ENST00000409879.2
|
KIAA0226L
|
KIAA0226-like |
| chr1_+_47137445 | 2.08 |
ENST00000569393.1
ENST00000334122.4 ENST00000415500.1 |
TEX38
|
testis expressed 38 |
| chr3_-_3151664 | 2.06 |
ENST00000256452.3
ENST00000311981.8 ENST00000430514.2 ENST00000456302.1 |
IL5RA
|
interleukin 5 receptor, alpha |
| chr2_-_89399845 | 2.04 |
ENST00000479981.1
|
IGKV1-16
|
immunoglobulin kappa variable 1-16 |
| chr2_+_114163945 | 2.02 |
ENST00000453673.3
|
IGKV1OR2-108
|
immunoglobulin kappa variable 1/OR2-108 (non-functional) |
| chr2_-_89417335 | 1.98 |
ENST00000490686.1
|
IGKV1-17
|
immunoglobulin kappa variable 1-17 |
| chr16_-_30393752 | 1.97 |
ENST00000566517.1
ENST00000605106.1 |
SEPT1
SEPT1
|
septin 1 Uncharacterized protein |
| chr2_-_89340242 | 1.95 |
ENST00000480492.1
|
IGKV1-12
|
immunoglobulin kappa variable 1-12 |
| chr11_+_118215036 | 1.93 |
ENST00000392883.2
ENST00000532917.1 |
CD3G
|
CD3g molecule, gamma (CD3-TCR complex) |
| chr2_-_89247338 | 1.93 |
ENST00000496168.1
|
IGKV1-5
|
immunoglobulin kappa variable 1-5 |
| chr22_+_23154239 | 1.92 |
ENST00000390315.2
|
IGLV3-10
|
immunoglobulin lambda variable 3-10 |
| chr5_+_161494521 | 1.92 |
ENST00000356592.3
|
GABRG2
|
gamma-aminobutyric acid (GABA) A receptor, gamma 2 |
| chr20_-_42355629 | 1.92 |
ENST00000373003.1
|
GTSF1L
|
gametocyte specific factor 1-like |
| chr14_-_106967788 | 1.92 |
ENST00000390622.2
|
IGHV1-46
|
immunoglobulin heavy variable 1-46 |
| chr3_+_48264816 | 1.91 |
ENST00000296435.2
ENST00000576243.1 |
CAMP
|
cathelicidin antimicrobial peptide |
| chr14_-_106068065 | 1.89 |
ENST00000390541.2
|
IGHE
|
immunoglobulin heavy constant epsilon |
| chrX_+_123480194 | 1.88 |
ENST00000371139.4
|
SH2D1A
|
SH2 domain containing 1A |
| chrX_-_49121165 | 1.88 |
ENST00000376207.4
ENST00000376199.2 |
FOXP3
|
forkhead box P3 |
| chr22_+_23247030 | 1.88 |
ENST00000390324.2
|
IGLJ3
|
immunoglobulin lambda joining 3 |
| chr14_+_22236722 | 1.87 |
ENST00000390428.3
|
TRAV6
|
T cell receptor alpha variable 6 |
| chr12_-_32040123 | 1.86 |
ENST00000535163.1
|
RP11-428G5.5
|
RP11-428G5.5 |
| chr6_-_36725157 | 1.85 |
ENST00000393189.2
|
CPNE5
|
copine V |
| chr11_-_118213455 | 1.85 |
ENST00000300692.4
|
CD3D
|
CD3d molecule, delta (CD3-TCR complex) |
| chr14_-_106322288 | 1.84 |
ENST00000390559.2
|
IGHM
|
immunoglobulin heavy constant mu |
| chr20_+_44650348 | 1.84 |
ENST00000454036.2
|
SLC12A5
|
solute carrier family 12 (potassium/chloride transporter), member 5 |
| chr6_-_41715128 | 1.84 |
ENST00000356667.4
ENST00000373025.3 ENST00000425343.2 |
PGC
|
progastricsin (pepsinogen C) |
| chr3_+_114012819 | 1.83 |
ENST00000383671.3
|
TIGIT
|
T cell immunoreceptor with Ig and ITIM domains |
| chr4_-_164534657 | 1.82 |
ENST00000339875.5
|
MARCH1
|
membrane-associated ring finger (C3HC4) 1, E3 ubiquitin protein ligase |
| chr7_+_142000747 | 1.81 |
ENST00000455382.2
|
TRBV2
|
T cell receptor beta variable 2 |
| chr14_+_22392209 | 1.81 |
ENST00000390440.2
|
TRAV14DV4
|
T cell receptor alpha variable 14/delta variable 4 |
| chr2_-_89292422 | 1.81 |
ENST00000495489.1
|
IGKV1-8
|
immunoglobulin kappa variable 1-8 |
| chr19_+_17638059 | 1.81 |
ENST00000599164.1
ENST00000449408.2 ENST00000600871.1 ENST00000599124.1 |
FAM129C
|
family with sequence similarity 129, member C |
| chr19_+_17638041 | 1.80 |
ENST00000601861.1
|
FAM129C
|
family with sequence similarity 129, member C |
| chr4_-_57687847 | 1.79 |
ENST00000504762.1
ENST00000248701.4 ENST00000506738.1 |
SPINK2
|
serine peptidase inhibitor, Kazal type 2 (acrosin-trypsin inhibitor) |
| chr6_-_25042231 | 1.79 |
ENST00000510784.2
|
FAM65B
|
family with sequence similarity 65, member B |
| chr5_-_39274617 | 1.79 |
ENST00000510188.1
|
FYB
|
FYN binding protein |
| chr12_-_49463620 | 1.78 |
ENST00000550675.1
|
RHEBL1
|
Ras homolog enriched in brain like 1 |
| chr2_-_158345341 | 1.78 |
ENST00000435117.1
|
CYTIP
|
cytohesin 1 interacting protein |
| chr14_+_22591276 | 1.77 |
ENST00000390455.3
|
TRAV26-1
|
T cell receptor alpha variable 26-1 |
| chr1_+_66820058 | 1.77 |
ENST00000480109.2
|
PDE4B
|
phosphodiesterase 4B, cAMP-specific |
| chr17_+_7239821 | 1.76 |
ENST00000158762.3
ENST00000570457.2 |
ACAP1
|
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
| chr9_+_113431059 | 1.75 |
ENST00000416899.2
|
MUSK
|
muscle, skeletal, receptor tyrosine kinase |
| chr2_+_90121477 | 1.75 |
ENST00000483379.1
|
IGKV1D-17
|
immunoglobulin kappa variable 1D-17 |
| chr7_-_142198049 | 1.74 |
ENST00000471935.1
|
TRBV11-2
|
T cell receptor beta variable 11-2 |
| chr7_+_129984630 | 1.74 |
ENST00000355388.3
ENST00000497503.1 ENST00000463587.1 ENST00000461828.1 ENST00000494311.1 ENST00000466363.2 ENST00000485477.1 ENST00000431780.2 ENST00000474905.1 |
CPA5
|
carboxypeptidase A5 |
| chr13_-_46964177 | 1.74 |
ENST00000389908.3
|
KIAA0226L
|
KIAA0226-like |
| chr1_-_7913089 | 1.72 |
ENST00000361696.5
|
UTS2
|
urotensin 2 |
| chr22_+_23241661 | 1.71 |
ENST00000390322.2
|
IGLJ2
|
immunoglobulin lambda joining 2 |
| chr11_-_118213360 | 1.71 |
ENST00000529594.1
|
CD3D
|
CD3d molecule, delta (CD3-TCR complex) |
| chr5_+_156607829 | 1.70 |
ENST00000422843.3
|
ITK
|
IL2-inducible T-cell kinase |
| chr1_-_161600990 | 1.70 |
ENST00000531221.1
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b) |
| chr22_-_37608325 | 1.69 |
ENST00000328544.3
|
SSTR3
|
somatostatin receptor 3 |
| chr2_+_90060377 | 1.69 |
ENST00000436451.2
|
IGKV6D-21
|
immunoglobulin kappa variable 6D-21 (non-functional) |
| chr11_+_73675873 | 1.69 |
ENST00000537753.1
ENST00000542350.1 |
DNAJB13
|
DnaJ (Hsp40) homolog, subfamily B, member 13 |
| chr14_+_22675388 | 1.68 |
ENST00000390461.2
|
TRAV34
|
T cell receptor alpha variable 34 |
| chr14_+_22748980 | 1.67 |
ENST00000390465.2
|
TRAV38-2DV8
|
T cell receptor alpha variable 38-2/delta variable 8 |
| chr16_-_30394143 | 1.67 |
ENST00000321367.3
ENST00000571393.1 |
SEPT1
|
septin 1 |
| chr17_+_7239904 | 1.67 |
ENST00000575425.1
|
ACAP1
|
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
| chr14_+_22631122 | 1.66 |
ENST00000390458.3
|
TRAV29DV5
|
T cell receptor alpha variable 29/delta variable 5 (gene/pseudogene) |
| chr12_-_103889731 | 1.66 |
ENST00000552578.1
ENST00000548048.1 ENST00000315192.8 ENST00000548883.1 ENST00000378113.2 |
C12orf42
|
chromosome 12 open reading frame 42 |
| chr2_+_90139056 | 1.64 |
ENST00000492446.1
|
IGKV1D-16
|
immunoglobulin kappa variable 1D-16 |
| chr14_+_22386325 | 1.64 |
ENST00000390439.2
|
TRAV13-2
|
T cell receptor alpha variable 13-2 |
| chr14_-_107078851 | 1.64 |
ENST00000390628.2
|
IGHV1-58
|
immunoglobulin heavy variable 1-58 |
| chr17_+_31318886 | 1.64 |
ENST00000269053.3
ENST00000394638.1 |
SPACA3
|
sperm acrosome associated 3 |
| chr2_+_90198535 | 1.63 |
ENST00000390276.2
|
IGKV1D-12
|
immunoglobulin kappa variable 1D-12 |
| chr19_+_50922187 | 1.63 |
ENST00000595883.1
ENST00000597855.1 ENST00000596074.1 ENST00000439922.2 ENST00000594685.1 ENST00000270632.7 |
SPIB
|
Spi-B transcription factor (Spi-1/PU.1 related) |
| chrX_+_123480421 | 1.62 |
ENST00000477673.2
|
SH2D1A
|
SH2 domain containing 1A |
| chr1_-_26697236 | 1.62 |
ENST00000451801.1
ENST00000454975.1 |
ZNF683
|
zinc finger protein 683 |
| chr17_-_42452063 | 1.60 |
ENST00000588098.1
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) |
| chr15_-_44969086 | 1.60 |
ENST00000434130.1
ENST00000560780.1 |
PATL2
|
protein associated with topoisomerase II homolog 2 (yeast) |
| chr16_-_11617444 | 1.59 |
ENST00000598234.1
|
CTD-3088G3.8
|
Protein LOC388210 |
| chr7_-_142232071 | 1.58 |
ENST00000390364.3
|
TRBV10-1
|
T cell receptor beta variable 10-1(gene/pseudogene) |
| chr3_-_3152031 | 1.57 |
ENST00000383846.1
ENST00000427088.1 ENST00000446632.2 ENST00000438560.1 |
IL5RA
|
interleukin 5 receptor, alpha |
| chr9_+_113431029 | 1.57 |
ENST00000189978.5
ENST00000374448.4 ENST00000374440.3 |
MUSK
|
muscle, skeletal, receptor tyrosine kinase |
| chr19_+_42381173 | 1.57 |
ENST00000221972.3
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha |
| chr21_-_47352477 | 1.57 |
ENST00000593412.1
|
PRED62
|
Uncharacterized protein |
| chr14_+_22293618 | 1.56 |
ENST00000390432.2
|
TRAV10
|
T cell receptor alpha variable 10 |
| chr2_+_90458201 | 1.55 |
ENST00000603238.1
|
CH17-132F21.1
|
Uncharacterized protein |
| chr1_+_161677034 | 1.54 |
ENST00000349527.4
ENST00000309691.6 ENST00000294796.4 ENST00000367953.3 ENST00000367950.1 |
FCRLA
|
Fc receptor-like A |
| chr22_+_22676808 | 1.53 |
ENST00000390290.2
|
IGLV1-51
|
immunoglobulin lambda variable 1-51 |
| chr17_-_3819751 | 1.53 |
ENST00000225538.3
|
P2RX1
|
purinergic receptor P2X, ligand-gated ion channel, 1 |
| chr11_+_62186498 | 1.52 |
ENST00000278282.2
|
SCGB1A1
|
secretoglobin, family 1A, member 1 (uteroglobin) |
| chr17_-_34625719 | 1.52 |
ENST00000422211.2
ENST00000542124.1 |
CCL3L1
|
chemokine (C-C motif) ligand 3-like 1 |
| chrY_+_22737678 | 1.52 |
ENST00000382772.3
|
EIF1AY
|
eukaryotic translation initiation factor 1A, Y-linked |
| chr17_+_33448593 | 1.51 |
ENST00000158009.5
|
FNDC8
|
fibronectin type III domain containing 8 |
| chr7_+_142636603 | 1.51 |
ENST00000409607.3
|
C7orf34
|
chromosome 7 open reading frame 34 |
| chr6_+_35265586 | 1.51 |
ENST00000542066.1
ENST00000316637.5 |
DEF6
|
differentially expressed in FDCP 6 homolog (mouse) |
| chr1_+_110163202 | 1.51 |
ENST00000531203.1
ENST00000256578.3 |
AMPD2
|
adenosine monophosphate deaminase 2 |
| chr12_-_54689532 | 1.51 |
ENST00000540264.2
ENST00000312156.4 |
NFE2
|
nuclear factor, erythroid 2 |
| chr16_+_27438563 | 1.50 |
ENST00000395754.4
|
IL21R
|
interleukin 21 receptor |
| chr2_-_89568263 | 1.50 |
ENST00000473726.1
|
IGKV1-33
|
immunoglobulin kappa variable 1-33 |
| chr12_-_55378470 | 1.50 |
ENST00000524668.1
ENST00000533607.1 |
TESPA1
|
thymocyte expressed, positive selection associated 1 |
| chrX_-_6453159 | 1.50 |
ENST00000381089.3
ENST00000398729.1 |
VCX3A
|
variable charge, X-linked 3A |
| chr22_+_29876197 | 1.49 |
ENST00000310624.6
|
NEFH
|
neurofilament, heavy polypeptide |
| chr17_-_34524157 | 1.49 |
ENST00000378354.4
ENST00000394484.1 |
CCL3L3
|
chemokine (C-C motif) ligand 3-like 3 |
| chr19_-_49944806 | 1.49 |
ENST00000221485.3
|
SLC17A7
|
solute carrier family 17 (vesicular glutamate transporter), member 7 |
| chrX_+_47990039 | 1.48 |
ENST00000304270.5
|
SPACA5B
|
sperm acrosome associated 5B |
| chr2_-_89459813 | 1.48 |
ENST00000390256.2
|
IGKV6-21
|
immunoglobulin kappa variable 6-21 (non-functional) |
| chr3_-_149510553 | 1.48 |
ENST00000462519.2
ENST00000446160.1 ENST00000383050.3 |
ANKUB1
|
ankyrin repeat and ubiquitin domain containing 1 |
| chr11_-_64510409 | 1.48 |
ENST00000394429.1
ENST00000394428.1 |
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
| chr16_+_32859034 | 1.47 |
ENST00000567458.2
ENST00000560724.1 |
IGHV2OR16-5
|
immunoglobulin heavy variable 2/OR16-5 (non-functional) |
| chr22_-_37545972 | 1.46 |
ENST00000216223.5
|
IL2RB
|
interleukin 2 receptor, beta |
| chr7_+_72742178 | 1.46 |
ENST00000442793.1
ENST00000413573.2 ENST00000252037.4 |
FKBP6
|
FK506 binding protein 6, 36kDa |
| chr7_+_142636440 | 1.46 |
ENST00000458732.1
|
C7orf34
|
chromosome 7 open reading frame 34 |
| chr19_+_17858509 | 1.45 |
ENST00000594202.1
ENST00000252771.7 ENST00000389133.4 |
FCHO1
|
FCH domain only 1 |
| chr12_-_68553512 | 1.45 |
ENST00000229135.3
|
IFNG
|
interferon, gamma |
| chr17_-_38020392 | 1.45 |
ENST00000346872.3
ENST00000439167.2 ENST00000377945.3 ENST00000394189.2 ENST00000377944.3 ENST00000377958.2 ENST00000535189.1 ENST00000377952.2 |
IKZF3
|
IKAROS family zinc finger 3 (Aiolos) |
| chr7_+_142364193 | 1.45 |
ENST00000390397.2
|
TRBV24-1
|
T cell receptor beta variable 24-1 |
| chr7_+_142334156 | 1.45 |
ENST00000390394.3
|
TRBV20-1
|
T cell receptor beta variable 20-1 |
| chr15_+_58430368 | 1.44 |
ENST00000558772.1
ENST00000219919.4 |
AQP9
|
aquaporin 9 |
| chr17_-_73839792 | 1.44 |
ENST00000590762.1
|
UNC13D
|
unc-13 homolog D (C. elegans) |
| chr1_-_161600942 | 1.44 |
ENST00000421702.2
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b) |
| chr14_+_29236269 | 1.44 |
ENST00000313071.4
|
FOXG1
|
forkhead box G1 |
| chr12_-_57873329 | 1.44 |
ENST00000424809.2
|
ARHGAP9
|
Rho GTPase activating protein 9 |
| chr17_-_34417479 | 1.44 |
ENST00000225245.5
|
CCL3
|
chemokine (C-C motif) ligand 3 |
| chr22_+_22681656 | 1.44 |
ENST00000390291.2
|
IGLV1-50
|
immunoglobulin lambda variable 1-50 (non-functional) |
| chr7_-_142162390 | 1.43 |
ENST00000390371.3
|
TRBV6-6
|
T cell receptor beta variable 6-6 |
| chr14_+_22670455 | 1.43 |
ENST00000390460.1
|
TRAV26-2
|
T cell receptor alpha variable 26-2 |
| chr11_+_73676281 | 1.43 |
ENST00000543947.1
|
DNAJB13
|
DnaJ (Hsp40) homolog, subfamily B, member 13 |
| chr7_+_142045246 | 1.43 |
ENST00000390392.3
|
TRBV4-2
|
T cell receptor beta variable 4-2 |
| chr12_-_11422630 | 1.43 |
ENST00000381842.3
ENST00000538488.1 |
PRB3
|
proline-rich protein BstNI subfamily 3 |
| chr2_+_217735493 | 1.42 |
ENST00000456163.1
|
AC007557.1
|
HCG1816075; Uncharacterized protein |
| chr17_+_38673270 | 1.42 |
ENST00000578280.1
|
RP5-1028K7.2
|
RP5-1028K7.2 |
| chr17_-_38020379 | 1.42 |
ENST00000351680.3
ENST00000346243.3 ENST00000350532.3 ENST00000467757.1 ENST00000439016.2 |
IKZF3
|
IKAROS family zinc finger 3 (Aiolos) |
| chr7_-_38289173 | 1.42 |
ENST00000436911.2
|
TRGC2
|
T cell receptor gamma constant 2 |
| chr1_-_109399682 | 1.41 |
ENST00000369995.3
ENST00000370001.3 |
AKNAD1
|
AKNA domain containing 1 |
| chr13_+_43148281 | 1.41 |
ENST00000239849.6
ENST00000398795.2 ENST00000544862.1 |
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11 |
| chr14_-_50506589 | 1.41 |
ENST00000553914.2
|
RP11-58E21.3
|
RP11-58E21.3 |
| chrX_+_123480375 | 1.41 |
ENST00000360027.4
|
SH2D1A
|
SH2 domain containing 1A |
| chr2_-_89310012 | 1.41 |
ENST00000493819.1
|
IGKV1-9
|
immunoglobulin kappa variable 1-9 |
| chr14_-_106406090 | 1.40 |
ENST00000390593.2
|
IGHV6-1
|
immunoglobulin heavy variable 6-1 |
| chr19_-_4902877 | 1.40 |
ENST00000381781.2
|
ARRDC5
|
arrestin domain containing 5 |
| chr4_-_74853897 | 1.40 |
ENST00000296028.3
|
PPBP
|
pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) |
| chr11_+_35201826 | 1.40 |
ENST00000531873.1
|
CD44
|
CD44 molecule (Indian blood group) |
| chr17_+_72270380 | 1.40 |
ENST00000582036.1
ENST00000307504.5 |
DNAI2
|
dynein, axonemal, intermediate chain 2 |
| chr22_+_22550113 | 1.39 |
ENST00000390285.3
|
IGLV6-57
|
immunoglobulin lambda variable 6-57 |
| chr5_-_55529115 | 1.38 |
ENST00000513241.2
ENST00000341048.4 |
ANKRD55
|
ankyrin repeat domain 55 |
| chr14_-_107035208 | 1.38 |
ENST00000390626.2
|
IGHV5-51
|
immunoglobulin heavy variable 5-51 |
| chr12_-_10542617 | 1.38 |
ENST00000240618.6
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1 |
| chr6_+_6588316 | 1.37 |
ENST00000379953.2
|
LY86
|
lymphocyte antigen 86 |
| chr14_+_22554680 | 1.37 |
ENST00000390451.2
|
TRAV23DV6
|
T cell receptor alpha variable 23/delta variable 6 |
| chr1_-_162381907 | 1.37 |
ENST00000367929.2
ENST00000359567.3 |
SH2D1B
|
SH2 domain containing 1B |
| chr9_-_35618364 | 1.37 |
ENST00000378431.1
ENST00000378430.3 ENST00000259633.4 |
CD72
|
CD72 molecule |
| chr5_-_176056974 | 1.37 |
ENST00000510387.1
ENST00000506696.1 |
SNCB
|
synuclein, beta |
| chr4_-_5021164 | 1.36 |
ENST00000506508.1
ENST00000509419.1 ENST00000307746.4 |
CYTL1
|
cytokine-like 1 |
| chr19_+_544034 | 1.36 |
ENST00000592501.1
ENST00000264553.3 |
GZMM
|
granzyme M (lymphocyte met-ase 1) |
| chr19_-_39108643 | 1.36 |
ENST00000396857.2
|
MAP4K1
|
mitogen-activated protein kinase kinase kinase kinase 1 |
| chr18_+_54814288 | 1.36 |
ENST00000585477.1
|
BOD1L2
|
biorientation of chromosomes in cell division 1-like 2 |
| chr22_+_22385332 | 1.36 |
ENST00000390282.2
|
IGLV4-69
|
immunoglobulin lambda variable 4-69 |
| chr12_+_86268065 | 1.35 |
ENST00000551529.1
ENST00000256010.6 |
NTS
|
neurotensin |
| chrX_-_70329118 | 1.35 |
ENST00000374188.3
|
IL2RG
|
interleukin 2 receptor, gamma |
| chr7_+_24323782 | 1.35 |
ENST00000242152.2
ENST00000407573.1 |
NPY
|
neuropeptide Y |
| chr18_-_67614645 | 1.34 |
ENST00000577287.1
|
CD226
|
CD226 molecule |
| chr10_-_79397202 | 1.34 |
ENST00000372437.1
ENST00000372408.2 ENST00000372403.4 |
KCNMA1
|
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
| chr20_+_24929866 | 1.34 |
ENST00000480798.1
ENST00000376835.2 |
CST7
|
cystatin F (leukocystatin) |
| chr1_-_200992827 | 1.34 |
ENST00000332129.2
ENST00000422435.2 |
KIF21B
|
kinesin family member 21B |
| chr2_+_89952792 | 1.33 |
ENST00000390265.2
|
IGKV1D-33
|
immunoglobulin kappa variable 1D-33 |
| chr1_+_45140360 | 1.32 |
ENST00000418644.1
ENST00000458657.2 ENST00000441519.1 ENST00000535358.1 ENST00000445071.1 |
C1orf228
|
chromosome 1 open reading frame 228 |
Network of associatons between targets according to the STRING database.
First level regulatory network of GATA3
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.1 | 8.5 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
| 1.1 | 3.3 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
| 1.0 | 3.1 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
| 0.9 | 2.7 | GO:0072616 | interleukin-18 secretion(GO:0072616) |
| 0.9 | 2.7 | GO:1900073 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
| 0.8 | 2.4 | GO:0098884 | postsynaptic neurotransmitter receptor internalization(GO:0098884) |
| 0.8 | 1.5 | GO:0060559 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
| 0.7 | 2.2 | GO:2000502 | negative regulation of natural killer cell chemotaxis(GO:2000502) |
| 0.7 | 3.6 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
| 0.7 | 2.1 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
| 0.7 | 2.1 | GO:0002728 | negative regulation of natural killer cell cytokine production(GO:0002728) |
| 0.7 | 0.7 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
| 0.7 | 2.0 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
| 0.7 | 2.6 | GO:0002432 | granuloma formation(GO:0002432) |
| 0.6 | 3.2 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
| 0.6 | 1.8 | GO:0040040 | thermosensory behavior(GO:0040040) |
| 0.6 | 1.8 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
| 0.6 | 1.8 | GO:0002881 | negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
| 0.6 | 5.3 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
| 0.6 | 2.9 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
| 0.6 | 13.2 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.6 | 1.7 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
| 0.6 | 1.7 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
| 0.5 | 2.2 | GO:0002304 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
| 0.5 | 2.2 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.5 | 1.6 | GO:1902103 | metaphase/anaphase transition of meiotic cell cycle(GO:0044785) regulation of metaphase/anaphase transition of meiotic cell cycle(GO:1902102) negative regulation of metaphase/anaphase transition of meiotic cell cycle(GO:1902103) regulation of meiotic chromosome separation(GO:1905132) negative regulation of meiotic chromosome separation(GO:1905133) |
| 0.5 | 0.5 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
| 0.5 | 1.1 | GO:0035712 | T-helper 2 cell activation(GO:0035712) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
| 0.5 | 1.6 | GO:1903980 | positive regulation of microglial cell activation(GO:1903980) |
| 0.5 | 0.5 | GO:2000458 | astrocyte chemotaxis(GO:0035700) regulation of astrocyte chemotaxis(GO:2000458) |
| 0.5 | 1.0 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
| 0.5 | 4.9 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
| 0.5 | 3.9 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
| 0.5 | 1.4 | GO:0071848 | regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
| 0.5 | 1.4 | GO:0050894 | determination of affect(GO:0050894) |
| 0.4 | 1.3 | GO:1904344 | positive regulation of growth rate(GO:0040010) regulation of gastric mucosal blood circulation(GO:1904344) positive regulation of gastric mucosal blood circulation(GO:1904346) gastric mucosal blood circulation(GO:1990768) |
| 0.4 | 36.7 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
| 0.4 | 2.2 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
| 0.4 | 0.4 | GO:0055073 | cadmium ion homeostasis(GO:0055073) |
| 0.4 | 2.2 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
| 0.4 | 1.3 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 0.4 | 2.9 | GO:0048619 | embryonic genitalia morphogenesis(GO:0030538) embryonic hindgut morphogenesis(GO:0048619) |
| 0.4 | 2.5 | GO:2000501 | regulation of natural killer cell chemotaxis(GO:2000501) |
| 0.4 | 2.1 | GO:2000471 | regulation of hematopoietic stem cell migration(GO:2000471) positive regulation of hematopoietic stem cell migration(GO:2000473) |
| 0.4 | 1.2 | GO:0021718 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 0.4 | 1.2 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
| 0.4 | 4.8 | GO:0034465 | response to carbon monoxide(GO:0034465) |
| 0.4 | 2.0 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
| 0.4 | 1.2 | GO:0001812 | positive regulation of type I hypersensitivity(GO:0001812) |
| 0.4 | 3.5 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 0.4 | 2.3 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
| 0.4 | 1.2 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.4 | 1.5 | GO:0002554 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
| 0.4 | 2.3 | GO:0015855 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
| 0.4 | 9.1 | GO:0002717 | positive regulation of natural killer cell mediated immunity(GO:0002717) |
| 0.4 | 1.9 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
| 0.4 | 1.1 | GO:0003408 | optic cup formation involved in camera-type eye development(GO:0003408) |
| 0.4 | 0.4 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
| 0.4 | 1.5 | GO:0002384 | hepatic immune response(GO:0002384) |
| 0.4 | 0.7 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
| 0.4 | 1.1 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) type B pancreatic cell maturation(GO:0072560) |
| 0.4 | 1.8 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
| 0.4 | 0.4 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 0.4 | 1.4 | GO:1904172 | regulation of bleb assembly(GO:1904170) positive regulation of bleb assembly(GO:1904172) |
| 0.4 | 0.4 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
| 0.4 | 3.9 | GO:0032264 | IMP salvage(GO:0032264) |
| 0.3 | 2.1 | GO:0033082 | regulation of extrathymic T cell differentiation(GO:0033082) |
| 0.3 | 1.0 | GO:1990709 | presynaptic active zone organization(GO:1990709) |
| 0.3 | 1.0 | GO:0048162 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
| 0.3 | 1.7 | GO:2000470 | negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) positive regulation of peroxidase activity(GO:2000470) |
| 0.3 | 1.0 | GO:1904717 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.3 | 2.0 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 0.3 | 3.9 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
| 0.3 | 1.3 | GO:0018963 | phthalate metabolic process(GO:0018963) |
| 0.3 | 1.9 | GO:0021633 | optic nerve structural organization(GO:0021633) |
| 0.3 | 1.0 | GO:0019516 | lactate oxidation(GO:0019516) |
| 0.3 | 0.6 | GO:2000309 | positive regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000309) |
| 0.3 | 1.6 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
| 0.3 | 1.2 | GO:1990926 | short-term synaptic potentiation(GO:1990926) |
| 0.3 | 0.3 | GO:0006760 | folic acid-containing compound metabolic process(GO:0006760) folic acid metabolic process(GO:0046655) |
| 0.3 | 1.5 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
| 0.3 | 4.1 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
| 0.3 | 0.9 | GO:0072720 | response to dithiothreitol(GO:0072720) |
| 0.3 | 0.9 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 0.3 | 0.6 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
| 0.3 | 4.7 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.3 | 0.9 | GO:2000627 | regulation of miRNA catabolic process(GO:2000625) positive regulation of miRNA catabolic process(GO:2000627) |
| 0.3 | 0.3 | GO:2000974 | negative regulation of pro-B cell differentiation(GO:2000974) |
| 0.3 | 0.3 | GO:0006887 | exocytosis(GO:0006887) |
| 0.3 | 0.9 | GO:0045556 | TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
| 0.3 | 2.0 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
| 0.3 | 1.4 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
| 0.3 | 0.8 | GO:0000349 | generation of catalytic spliceosome for first transesterification step(GO:0000349) |
| 0.3 | 0.8 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
| 0.3 | 1.1 | GO:0061056 | sclerotome development(GO:0061056) |
| 0.3 | 0.8 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
| 0.3 | 0.5 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
| 0.3 | 0.8 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
| 0.3 | 0.5 | GO:1903726 | negative regulation of phospholipid metabolic process(GO:1903726) |
| 0.3 | 0.3 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
| 0.3 | 1.1 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.3 | 1.6 | GO:0038112 | interleukin-8-mediated signaling pathway(GO:0038112) |
| 0.3 | 0.8 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.3 | 0.5 | GO:0021586 | pons maturation(GO:0021586) |
| 0.3 | 1.3 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
| 0.3 | 0.5 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
| 0.3 | 9.8 | GO:0045730 | respiratory burst(GO:0045730) |
| 0.3 | 0.8 | GO:0001694 | histamine biosynthetic process(GO:0001694) |
| 0.3 | 0.3 | GO:1900111 | positive regulation of histone H3-K9 dimethylation(GO:1900111) |
| 0.3 | 5.8 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
| 0.3 | 0.8 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
| 0.2 | 0.2 | GO:1900228 | biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
| 0.2 | 0.2 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
| 0.2 | 1.5 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
| 0.2 | 0.7 | GO:0030185 | nitric oxide transport(GO:0030185) |
| 0.2 | 52.3 | GO:0002377 | immunoglobulin production(GO:0002377) |
| 0.2 | 0.7 | GO:0060304 | regulation of phosphatidylinositol dephosphorylation(GO:0060304) |
| 0.2 | 1.7 | GO:0003185 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
| 0.2 | 0.7 | GO:0072738 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
| 0.2 | 5.3 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
| 0.2 | 1.2 | GO:0007538 | primary sex determination(GO:0007538) |
| 0.2 | 0.5 | GO:0021558 | trochlear nerve development(GO:0021558) |
| 0.2 | 1.9 | GO:0051712 | positive regulation of killing of cells of other organism(GO:0051712) |
| 0.2 | 1.4 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 0.2 | 0.7 | GO:0060166 | olfactory pit development(GO:0060166) |
| 0.2 | 0.9 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
| 0.2 | 0.5 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
| 0.2 | 0.5 | GO:0002503 | peptide antigen assembly with MHC class II protein complex(GO:0002503) |
| 0.2 | 0.5 | GO:0045732 | positive regulation of protein catabolic process(GO:0045732) |
| 0.2 | 0.9 | GO:1902523 | positive regulation of protein K63-linked ubiquitination(GO:1902523) |
| 0.2 | 0.5 | GO:0034130 | toll-like receptor 1 signaling pathway(GO:0034130) |
| 0.2 | 0.2 | GO:0010644 | cell communication by electrical coupling(GO:0010644) |
| 0.2 | 0.2 | GO:0071467 | cellular response to pH(GO:0071467) |
| 0.2 | 0.5 | GO:1990927 | calcium ion regulated lysosome exocytosis(GO:1990927) |
| 0.2 | 0.7 | GO:0021577 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
| 0.2 | 0.2 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
| 0.2 | 0.7 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) granzyme B production(GO:0071613) regulation of granzyme B production(GO:0071661) positive regulation of granzyme B production(GO:0071663) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
| 0.2 | 0.7 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
| 0.2 | 2.0 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 0.2 | 1.8 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.2 | 0.7 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
| 0.2 | 1.3 | GO:0016198 | axon choice point recognition(GO:0016198) |
| 0.2 | 0.2 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
| 0.2 | 5.8 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 0.2 | 0.2 | GO:0006304 | DNA modification(GO:0006304) |
| 0.2 | 0.2 | GO:1903487 | regulation of lactation(GO:1903487) |
| 0.2 | 0.4 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
| 0.2 | 0.6 | GO:0002372 | myeloid dendritic cell cytokine production(GO:0002372) |
| 0.2 | 0.4 | GO:0098700 | neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.2 | 1.0 | GO:0006540 | glutamate decarboxylation to succinate(GO:0006540) |
| 0.2 | 0.6 | GO:0060380 | regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) |
| 0.2 | 0.8 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
| 0.2 | 0.6 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 0.2 | 0.8 | GO:0051541 | elastin metabolic process(GO:0051541) |
| 0.2 | 1.4 | GO:0001661 | conditioned taste aversion(GO:0001661) |
| 0.2 | 0.4 | GO:0005988 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
| 0.2 | 0.4 | GO:0006972 | hyperosmotic response(GO:0006972) |
| 0.2 | 42.6 | GO:0002433 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
| 0.2 | 0.8 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
| 0.2 | 6.6 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
| 0.2 | 0.8 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
| 0.2 | 0.4 | GO:2000547 | regulation of dendritic cell dendrite assembly(GO:2000547) |
| 0.2 | 0.8 | GO:0050975 | sensory perception of touch(GO:0050975) detection of mechanical stimulus involved in sensory perception of touch(GO:0050976) |
| 0.2 | 1.9 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
| 0.2 | 0.8 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
| 0.2 | 0.4 | GO:0043474 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
| 0.2 | 1.5 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
| 0.2 | 1.3 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
| 0.2 | 0.4 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 0.2 | 0.6 | GO:0033037 | polysaccharide localization(GO:0033037) |
| 0.2 | 2.6 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.2 | 0.6 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
| 0.2 | 0.2 | GO:2000058 | regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000058) |
| 0.2 | 0.6 | GO:1904316 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
| 0.2 | 0.6 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
| 0.2 | 0.2 | GO:0070163 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) negative regulation of adiponectin secretion(GO:0070164) |
| 0.2 | 4.5 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
| 0.2 | 1.3 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
| 0.2 | 1.5 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
| 0.2 | 0.9 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.2 | 1.1 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.2 | 0.7 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 0.2 | 0.2 | GO:0060458 | right lung development(GO:0060458) |
| 0.2 | 4.1 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
| 0.2 | 0.5 | GO:0007057 | spindle assembly involved in female meiosis I(GO:0007057) |
| 0.2 | 0.9 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
| 0.2 | 0.2 | GO:0071393 | cellular response to progesterone stimulus(GO:0071393) |
| 0.2 | 0.7 | GO:0021816 | lamellipodium assembly involved in ameboidal cell migration(GO:0003363) extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
| 0.2 | 0.4 | GO:1903413 | cellular response to bile acid(GO:1903413) |
| 0.2 | 1.1 | GO:0008343 | adult feeding behavior(GO:0008343) |
| 0.2 | 2.6 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 0.2 | 0.7 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
| 0.2 | 1.2 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
| 0.2 | 0.5 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
| 0.2 | 1.0 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.2 | 0.7 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) |
| 0.2 | 0.9 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
| 0.2 | 0.2 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 0.2 | 0.3 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
| 0.2 | 2.2 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
| 0.2 | 1.2 | GO:0071461 | cellular response to redox state(GO:0071461) |
| 0.2 | 0.5 | GO:0035524 | proline transmembrane transport(GO:0035524) |
| 0.2 | 1.0 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
| 0.2 | 2.0 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
| 0.2 | 0.7 | GO:2000435 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
| 0.2 | 0.2 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
| 0.2 | 3.3 | GO:0001675 | acrosome assembly(GO:0001675) |
| 0.2 | 3.8 | GO:0071420 | cellular response to histamine(GO:0071420) |
| 0.2 | 1.0 | GO:0061760 | antifungal innate immune response(GO:0061760) |
| 0.2 | 0.8 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 0.2 | 2.6 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
| 0.2 | 3.0 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
| 0.2 | 0.8 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
| 0.2 | 0.2 | GO:0044335 | canonical Wnt signaling pathway involved in neural crest cell differentiation(GO:0044335) |
| 0.2 | 0.5 | GO:0032847 | regulation of cellular pH reduction(GO:0032847) positive regulation of cellular pH reduction(GO:0032849) |
| 0.2 | 1.3 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 0.2 | 0.3 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
| 0.2 | 0.6 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.2 | 1.8 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
| 0.2 | 0.8 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
| 0.2 | 0.5 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
| 0.2 | 0.9 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
| 0.2 | 0.5 | GO:1900276 | negative regulation of phospholipase C activity(GO:1900275) regulation of proteinase activated receptor activity(GO:1900276) negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900737) |
| 0.2 | 0.6 | GO:2000866 | positive regulation of estrogen secretion(GO:2000863) positive regulation of estradiol secretion(GO:2000866) |
| 0.2 | 0.3 | GO:0048867 | ganglion mother cell fate determination(GO:0007402) stem cell fate determination(GO:0048867) |
| 0.2 | 1.2 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
| 0.2 | 0.8 | GO:0061502 | uropod organization(GO:0032796) early endosome to recycling endosome transport(GO:0061502) |
| 0.2 | 0.8 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
| 0.2 | 0.3 | GO:0002476 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib(GO:0002476) |
| 0.2 | 5.1 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 0.2 | 0.6 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
| 0.2 | 0.5 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
| 0.2 | 3.8 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
| 0.2 | 1.7 | GO:0001865 | NK T cell differentiation(GO:0001865) |
| 0.1 | 1.8 | GO:1903416 | response to glycoside(GO:1903416) |
| 0.1 | 0.3 | GO:1901017 | negative regulation of potassium ion transmembrane transporter activity(GO:1901017) negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
| 0.1 | 0.4 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
| 0.1 | 0.1 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
| 0.1 | 1.5 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 0.1 | 0.4 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
| 0.1 | 0.1 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
| 0.1 | 0.3 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
| 0.1 | 0.6 | GO:0032456 | endocytic recycling(GO:0032456) |
| 0.1 | 0.7 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
| 0.1 | 0.7 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
| 0.1 | 0.7 | GO:0030223 | neutrophil differentiation(GO:0030223) |
| 0.1 | 0.4 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
| 0.1 | 0.9 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
| 0.1 | 0.7 | GO:0001880 | Mullerian duct regression(GO:0001880) |
| 0.1 | 0.4 | GO:0035493 | SNARE complex assembly(GO:0035493) |
| 0.1 | 2.4 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
| 0.1 | 0.1 | GO:0035967 | endoplasmic reticulum unfolded protein response(GO:0030968) cellular response to topologically incorrect protein(GO:0035967) |
| 0.1 | 0.4 | GO:0003006 | developmental process involved in reproduction(GO:0003006) |
| 0.1 | 1.0 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
| 0.1 | 0.4 | GO:0045819 | positive regulation of glycogen catabolic process(GO:0045819) |
| 0.1 | 1.1 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.1 | 2.8 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
| 0.1 | 2.7 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
| 0.1 | 1.1 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.1 | 2.9 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.1 | 0.1 | GO:1903093 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
| 0.1 | 0.3 | GO:0051705 | multi-organism behavior(GO:0051705) |
| 0.1 | 0.6 | GO:0044725 | chromatin reprogramming in the zygote(GO:0044725) |
| 0.1 | 0.1 | GO:0021794 | thalamus development(GO:0021794) |
| 0.1 | 1.6 | GO:0043383 | negative T cell selection(GO:0043383) |
| 0.1 | 0.3 | GO:0046967 | cytosol to ER transport(GO:0046967) |
| 0.1 | 0.1 | GO:0035566 | regulation of metanephros size(GO:0035566) |
| 0.1 | 1.9 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
| 0.1 | 0.3 | GO:0042109 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
| 0.1 | 0.4 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
| 0.1 | 0.4 | GO:0046968 | peptide antigen transport(GO:0046968) |
| 0.1 | 0.3 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
| 0.1 | 1.3 | GO:0044146 | negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
| 0.1 | 0.4 | GO:0039521 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) suppression by virus of host autophagy(GO:0039521) |
| 0.1 | 8.9 | GO:0042100 | B cell proliferation(GO:0042100) |
| 0.1 | 1.1 | GO:0019883 | antigen processing and presentation of endogenous antigen(GO:0019883) |
| 0.1 | 1.0 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
| 0.1 | 0.5 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.1 | 0.1 | GO:0045901 | translational frameshifting(GO:0006452) positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
| 0.1 | 0.6 | GO:0035709 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
| 0.1 | 0.5 | GO:1903045 | neural crest cell migration involved in sympathetic nervous system development(GO:1903045) |
| 0.1 | 0.9 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
| 0.1 | 2.9 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
| 0.1 | 0.4 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
| 0.1 | 0.4 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.1 | 7.2 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
| 0.1 | 1.4 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
| 0.1 | 1.1 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 0.1 | 0.5 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
| 0.1 | 0.4 | GO:0070781 | response to biotin(GO:0070781) |
| 0.1 | 0.6 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.1 | 0.9 | GO:1904550 | chemotaxis to arachidonic acid(GO:0034670) response to arachidonic acid(GO:1904550) |
| 0.1 | 0.2 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
| 0.1 | 1.1 | GO:1902748 | melanocyte migration(GO:0097324) positive regulation of lens fiber cell differentiation(GO:1902748) |
| 0.1 | 0.1 | GO:1903936 | response to sodium arsenite(GO:1903935) cellular response to sodium arsenite(GO:1903936) |
| 0.1 | 0.7 | GO:0071918 | urea transmembrane transport(GO:0071918) |
| 0.1 | 1.3 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.1 | 0.7 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
| 0.1 | 2.5 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
| 0.1 | 0.1 | GO:1904867 | regulation of establishment of protein localization to telomere(GO:0070203) protein localization to nuclear body(GO:1903405) positive regulation of establishment of protein localization to telomere(GO:1904851) protein localization to Cajal body(GO:1904867) protein localization to nucleoplasm(GO:1990173) |
| 0.1 | 0.2 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
| 0.1 | 0.4 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.1 | 2.1 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
| 0.1 | 0.4 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
| 0.1 | 1.6 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 0.1 | 0.7 | GO:0044700 | single organism signaling(GO:0044700) |
| 0.1 | 0.3 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
| 0.1 | 0.7 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
| 0.1 | 0.9 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
| 0.1 | 0.2 | GO:0071586 | CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
| 0.1 | 0.3 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
| 0.1 | 0.9 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.1 | 1.4 | GO:0048505 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
| 0.1 | 0.7 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) |
| 0.1 | 0.5 | GO:0043308 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil activation(GO:0043307) eosinophil degranulation(GO:0043308) |
| 0.1 | 0.8 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 0.1 | 0.3 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
| 0.1 | 1.3 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
| 0.1 | 0.7 | GO:0098707 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 0.1 | 0.3 | GO:0071317 | cellular response to morphine(GO:0071315) cellular response to isoquinoline alkaloid(GO:0071317) |
| 0.1 | 17.7 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.1 | 0.2 | GO:0034165 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
| 0.1 | 1.7 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
| 0.1 | 0.7 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
| 0.1 | 0.9 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
| 0.1 | 0.4 | GO:0035397 | helper T cell enhancement of adaptive immune response(GO:0035397) |
| 0.1 | 1.2 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
| 0.1 | 0.8 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
| 0.1 | 1.4 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
| 0.1 | 0.3 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
| 0.1 | 1.8 | GO:0035587 | purinergic receptor signaling pathway(GO:0035587) |
| 0.1 | 0.4 | GO:0030033 | microvillus assembly(GO:0030033) |
| 0.1 | 4.7 | GO:0002228 | natural killer cell mediated immunity(GO:0002228) |
| 0.1 | 1.5 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.1 | 2.1 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
| 0.1 | 0.1 | GO:0097278 | complement-dependent cytotoxicity(GO:0097278) |
| 0.1 | 0.4 | GO:0019046 | release from viral latency(GO:0019046) |
| 0.1 | 2.3 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.1 | 0.8 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
| 0.1 | 0.2 | GO:0033344 | cholesterol efflux(GO:0033344) |
| 0.1 | 1.0 | GO:0097338 | response to clozapine(GO:0097338) |
| 0.1 | 2.1 | GO:0034605 | cellular response to heat(GO:0034605) |
| 0.1 | 0.1 | GO:0048382 | mesendoderm development(GO:0048382) |
| 0.1 | 0.8 | GO:0045007 | depurination(GO:0045007) |
| 0.1 | 0.2 | GO:0021559 | trigeminal nerve development(GO:0021559) |
| 0.1 | 0.9 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
| 0.1 | 0.3 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.1 | 0.5 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.1 | 2.2 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 0.1 | 0.4 | GO:0016240 | autophagosome docking(GO:0016240) |
| 0.1 | 0.4 | GO:0043605 | cellular amide catabolic process(GO:0043605) |
| 0.1 | 0.5 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
| 0.1 | 0.2 | GO:1904744 | positive regulation of telomeric DNA binding(GO:1904744) |
| 0.1 | 0.7 | GO:0043585 | nose morphogenesis(GO:0043585) |
| 0.1 | 1.3 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
| 0.1 | 0.6 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
| 0.1 | 0.5 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
| 0.1 | 0.9 | GO:0006772 | thiamine metabolic process(GO:0006772) |
| 0.1 | 3.5 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.1 | 0.3 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 0.1 | 0.9 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 0.1 | 0.3 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
| 0.1 | 0.2 | GO:1903422 | negative regulation of synaptic vesicle recycling(GO:1903422) |
| 0.1 | 0.2 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
| 0.1 | 0.2 | GO:1901796 | regulation of signal transduction by p53 class mediator(GO:1901796) |
| 0.1 | 1.2 | GO:0021702 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
| 0.1 | 1.0 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
| 0.1 | 1.5 | GO:0060134 | prepulse inhibition(GO:0060134) |
| 0.1 | 0.1 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
| 0.1 | 0.3 | GO:1901876 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 0.1 | 1.2 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.1 | 0.5 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
| 0.1 | 1.1 | GO:0099612 | protein localization to axon(GO:0099612) |
| 0.1 | 0.4 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
| 0.1 | 0.3 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
| 0.1 | 0.5 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
| 0.1 | 0.5 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
| 0.1 | 0.7 | GO:0002517 | T cell tolerance induction(GO:0002517) |
| 0.1 | 2.0 | GO:0050855 | regulation of B cell receptor signaling pathway(GO:0050855) |
| 0.1 | 0.5 | GO:0008204 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
| 0.1 | 0.2 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) |
| 0.1 | 0.3 | GO:1904247 | positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
| 0.1 | 1.0 | GO:0050957 | equilibrioception(GO:0050957) |
| 0.1 | 1.0 | GO:0045187 | regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
| 0.1 | 0.3 | GO:0006424 | glutamyl-tRNA aminoacylation(GO:0006424) |
| 0.1 | 2.9 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
| 0.1 | 0.4 | GO:0071440 | regulation of histone H3-K14 acetylation(GO:0071440) |
| 0.1 | 0.7 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.1 | 0.4 | GO:0030308 | negative regulation of cell growth(GO:0030308) |
| 0.1 | 0.7 | GO:0072520 | seminiferous tubule development(GO:0072520) |
| 0.1 | 1.0 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
| 0.1 | 0.4 | GO:0046643 | regulation of gamma-delta T cell activation(GO:0046643) |
| 0.1 | 4.2 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.1 | 0.4 | GO:0051205 | protein insertion into membrane(GO:0051205) |
| 0.1 | 0.2 | GO:0021550 | noradrenergic neuron development(GO:0003358) medulla oblongata development(GO:0021550) |
| 0.1 | 0.4 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
| 0.1 | 0.2 | GO:0046101 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
| 0.1 | 0.3 | GO:0072185 | metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.1 | 0.6 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
| 0.1 | 2.7 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
| 0.1 | 0.4 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
| 0.1 | 3.6 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 0.1 | 0.2 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.1 | 0.3 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
| 0.1 | 0.4 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
| 0.1 | 0.3 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
| 0.1 | 4.8 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.1 | 0.3 | GO:0090290 | regulation of osteoclast proliferation(GO:0090289) positive regulation of osteoclast proliferation(GO:0090290) |
| 0.1 | 0.7 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
| 0.1 | 0.1 | GO:1990918 | double-strand break repair involved in meiotic recombination(GO:1990918) |
| 0.1 | 0.3 | GO:1904044 | peptidyl-serine ADP-ribosylation(GO:0018312) response to aldosterone(GO:1904044) |
| 0.1 | 0.3 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
| 0.1 | 0.1 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
| 0.1 | 0.4 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.1 | 5.4 | GO:0045576 | mast cell activation(GO:0045576) |
| 0.1 | 1.0 | GO:0009304 | tRNA transcription(GO:0009304) |
| 0.1 | 0.9 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.1 | 0.2 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
| 0.1 | 0.7 | GO:0045006 | DNA deamination(GO:0045006) |
| 0.1 | 2.5 | GO:0031498 | chromatin disassembly(GO:0031498) |
| 0.1 | 1.4 | GO:0045141 | meiotic telomere clustering(GO:0045141) |
| 0.1 | 0.2 | GO:0021514 | ventral spinal cord interneuron differentiation(GO:0021514) |
| 0.1 | 0.5 | GO:0071287 | cellular response to manganese ion(GO:0071287) |
| 0.1 | 0.4 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.1 | 0.6 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
| 0.1 | 0.9 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
| 0.1 | 0.8 | GO:0045959 | regulation of complement activation, classical pathway(GO:0030450) negative regulation of complement activation, classical pathway(GO:0045959) |
| 0.1 | 0.6 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
| 0.1 | 0.5 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
| 0.1 | 0.3 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.1 | 0.2 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
| 0.1 | 0.5 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
| 0.1 | 0.1 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.1 | 0.5 | GO:0051026 | chiasma assembly(GO:0051026) |
| 0.1 | 0.6 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
| 0.1 | 0.4 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.1 | 0.5 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
| 0.1 | 0.2 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
| 0.1 | 0.9 | GO:0042940 | D-amino acid transport(GO:0042940) |
| 0.1 | 0.9 | GO:0035855 | megakaryocyte development(GO:0035855) |
| 0.1 | 0.1 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
| 0.1 | 0.5 | GO:0070269 | pyroptosis(GO:0070269) |
| 0.1 | 0.3 | GO:0021825 | substrate-dependent cerebral cortex tangential migration(GO:0021825) |
| 0.1 | 1.1 | GO:0075713 | establishment of integrated proviral latency(GO:0075713) |
| 0.1 | 1.3 | GO:0030168 | platelet activation(GO:0030168) |
| 0.1 | 0.9 | GO:0070307 | lens fiber cell development(GO:0070307) |
| 0.1 | 0.7 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
| 0.1 | 0.2 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.1 | 0.4 | GO:0006642 | triglyceride mobilization(GO:0006642) |
| 0.1 | 0.9 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.1 | 0.5 | GO:1901318 | negative regulation of sperm motility(GO:1901318) |
| 0.1 | 0.4 | GO:0031627 | telomeric loop formation(GO:0031627) |
| 0.1 | 0.4 | GO:1903378 | positive regulation of oxidative stress-induced neuron death(GO:1903223) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.1 | 0.4 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
| 0.1 | 3.6 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
| 0.1 | 0.5 | GO:0033504 | floor plate development(GO:0033504) |
| 0.1 | 0.1 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
| 0.1 | 0.1 | GO:0008355 | olfactory learning(GO:0008355) |
| 0.1 | 0.6 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.1 | 0.7 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.1 | 0.1 | GO:0010692 | regulation of alkaline phosphatase activity(GO:0010692) |
| 0.1 | 0.1 | GO:0044702 | single organism reproductive process(GO:0044702) |
| 0.1 | 0.4 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
| 0.1 | 0.9 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
| 0.1 | 0.4 | GO:0018057 | peptidyl-lysine oxidation(GO:0018057) |
| 0.1 | 0.4 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
| 0.1 | 0.2 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.1 | 0.1 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
| 0.1 | 0.2 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
| 0.1 | 1.4 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.1 | 0.2 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.1 | 0.5 | GO:0042832 | defense response to protozoan(GO:0042832) |
| 0.1 | 0.4 | GO:0031017 | exocrine pancreas development(GO:0031017) |
| 0.1 | 0.1 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
| 0.1 | 0.3 | GO:0035627 | ceramide transport(GO:0035627) |
| 0.1 | 1.6 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
| 0.1 | 1.7 | GO:0030220 | platelet formation(GO:0030220) |
| 0.1 | 0.1 | GO:0048318 | axial mesoderm development(GO:0048318) |
| 0.1 | 2.0 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
| 0.1 | 0.1 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
| 0.1 | 0.4 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.1 | 0.1 | GO:0019042 | viral latency(GO:0019042) establishment of viral latency(GO:0019043) regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) negative regulation of macrophage apoptotic process(GO:2000110) |
| 0.1 | 0.3 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 0.1 | 0.6 | GO:0018212 | peptidyl-tyrosine modification(GO:0018212) |
| 0.1 | 0.3 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
| 0.1 | 0.3 | GO:2000834 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
| 0.1 | 0.6 | GO:1990034 | calcium ion export from cell(GO:1990034) |
| 0.1 | 0.2 | GO:1903412 | response to bile acid(GO:1903412) |
| 0.1 | 0.5 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
| 0.1 | 0.3 | GO:0007343 | egg activation(GO:0007343) |
| 0.1 | 0.3 | GO:1903597 | negative regulation of gap junction assembly(GO:1903597) |
| 0.1 | 2.7 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
| 0.1 | 0.2 | GO:0014908 | myotube differentiation involved in skeletal muscle regeneration(GO:0014908) |
| 0.1 | 0.5 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.1 | 1.9 | GO:0046710 | GDP metabolic process(GO:0046710) |
| 0.1 | 0.6 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.1 | 0.3 | GO:0036292 | DNA rewinding(GO:0036292) |
| 0.1 | 0.1 | GO:0046778 | modification by virus of host mRNA processing(GO:0046778) |
| 0.1 | 0.3 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.1 | 0.4 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
| 0.1 | 0.3 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
| 0.1 | 0.4 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
| 0.1 | 0.3 | GO:0019417 | sulfur oxidation(GO:0019417) |
| 0.1 | 0.3 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
| 0.1 | 0.3 | GO:1990502 | dense core granule maturation(GO:1990502) |
| 0.1 | 0.1 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
| 0.1 | 3.4 | GO:0030317 | sperm motility(GO:0030317) |
| 0.1 | 0.2 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.1 | 1.2 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
| 0.1 | 2.8 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.1 | 1.1 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.1 | 3.3 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
| 0.1 | 0.3 | GO:0050890 | cognition(GO:0050890) |
| 0.1 | 0.2 | GO:0001555 | oocyte growth(GO:0001555) |
| 0.1 | 1.0 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.1 | 0.8 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
| 0.1 | 0.9 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.1 | 0.2 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
| 0.1 | 0.4 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
| 0.1 | 0.4 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.1 | 0.7 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.1 | 0.2 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.1 | 0.4 | GO:0043144 | snoRNA processing(GO:0043144) |
| 0.1 | 0.4 | GO:0019075 | virus maturation(GO:0019075) |
| 0.1 | 0.2 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
| 0.1 | 2.6 | GO:0008089 | anterograde axonal transport(GO:0008089) |
| 0.1 | 3.9 | GO:0031295 | T cell costimulation(GO:0031295) |
| 0.1 | 0.2 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
| 0.1 | 0.5 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.1 | 0.2 | GO:0039656 | modulation by virus of host gene expression(GO:0039656) |
| 0.1 | 0.4 | GO:1900063 | regulation of peroxisome organization(GO:1900063) |
| 0.1 | 0.2 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
| 0.1 | 0.8 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
| 0.1 | 0.6 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
| 0.1 | 0.8 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
| 0.1 | 0.2 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) |
| 0.1 | 0.5 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.1 | 0.6 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.1 | 3.3 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 0.1 | 0.2 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.1 | 0.3 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
| 0.1 | 0.3 | GO:0048496 | maintenance of organ identity(GO:0048496) |
| 0.1 | 0.3 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
| 0.1 | 0.5 | GO:0030259 | lipid glycosylation(GO:0030259) |
| 0.1 | 0.1 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
| 0.1 | 0.2 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
| 0.1 | 0.2 | GO:0035508 | positive regulation of myosin-light-chain-phosphatase activity(GO:0035508) |
| 0.1 | 1.2 | GO:0044705 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
| 0.1 | 0.8 | GO:0033227 | dsRNA transport(GO:0033227) |
| 0.1 | 0.2 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
| 0.1 | 0.6 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
| 0.1 | 0.3 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.1 | 0.2 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 0.1 | 0.3 | GO:0015846 | polyamine transport(GO:0015846) |
| 0.1 | 0.2 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.1 | 0.1 | GO:0015960 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.1 | 0.8 | GO:0014029 | neural crest formation(GO:0014029) |
| 0.1 | 0.4 | GO:0098704 | fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
| 0.1 | 0.2 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 0.1 | 0.9 | GO:0070977 | bone maturation(GO:0070977) |
| 0.1 | 0.7 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.1 | 0.3 | GO:0043010 | camera-type eye development(GO:0043010) |
| 0.1 | 0.3 | GO:0031034 | myosin filament organization(GO:0031033) myosin filament assembly(GO:0031034) striated muscle myosin thick filament assembly(GO:0071688) |
| 0.1 | 0.8 | GO:0051382 | kinetochore assembly(GO:0051382) |
| 0.1 | 0.9 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
| 0.1 | 1.0 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
| 0.1 | 0.3 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.1 | 0.2 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.1 | 0.4 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
| 0.1 | 0.6 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 0.1 | 0.3 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
| 0.1 | 2.2 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
| 0.1 | 1.2 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.1 | 2.1 | GO:0030593 | neutrophil chemotaxis(GO:0030593) |
| 0.1 | 0.1 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
| 0.1 | 0.3 | GO:0010818 | T cell chemotaxis(GO:0010818) |
| 0.1 | 0.8 | GO:0006265 | DNA topological change(GO:0006265) |
| 0.1 | 0.3 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
| 0.1 | 2.6 | GO:0050672 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
| 0.1 | 0.3 | GO:0032094 | response to food(GO:0032094) |
| 0.1 | 0.3 | GO:0000430 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) carbon catabolite activation of transcription(GO:0045991) positive regulation of transcription by glucose(GO:0046016) |
| 0.1 | 0.4 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
| 0.0 | 0.2 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.0 | 0.3 | GO:0038092 | nodal signaling pathway(GO:0038092) |
| 0.0 | 0.1 | GO:0035994 | response to muscle stretch(GO:0035994) |
| 0.0 | 0.5 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
| 0.0 | 0.4 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
| 0.0 | 0.6 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.0 | 0.1 | GO:0007077 | mitotic nuclear envelope disassembly(GO:0007077) |
| 0.0 | 0.1 | GO:1905053 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 0.0 | 0.2 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
| 0.0 | 0.3 | GO:0035036 | sperm-egg recognition(GO:0035036) |
| 0.0 | 0.0 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
| 0.0 | 0.0 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
| 0.0 | 0.1 | GO:1903778 | protein localization to vacuolar membrane(GO:1903778) |
| 0.0 | 0.5 | GO:0018094 | protein polyglycylation(GO:0018094) |
| 0.0 | 0.0 | GO:1903423 | positive regulation of synaptic vesicle endocytosis(GO:1900244) positive regulation of synaptic vesicle transport(GO:1902805) positive regulation of synaptic vesicle recycling(GO:1903423) |
| 0.0 | 0.1 | GO:0032026 | response to magnesium ion(GO:0032026) |
| 0.0 | 0.2 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 0.0 | 0.6 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
| 0.0 | 0.7 | GO:0008340 | determination of adult lifespan(GO:0008340) |
| 0.0 | 0.4 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
| 0.0 | 2.5 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
| 0.0 | 0.2 | GO:0002544 | chronic inflammatory response(GO:0002544) |
| 0.0 | 0.4 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
| 0.0 | 0.1 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
| 0.0 | 0.2 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
| 0.0 | 0.3 | GO:0044245 | polysaccharide digestion(GO:0044245) |
| 0.0 | 0.1 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
| 0.0 | 0.0 | GO:0034776 | response to histamine(GO:0034776) |
| 0.0 | 0.4 | GO:0048710 | regulation of astrocyte differentiation(GO:0048710) |
| 0.0 | 0.1 | GO:0032053 | ciliary basal body organization(GO:0032053) |
| 0.0 | 0.7 | GO:0021542 | dentate gyrus development(GO:0021542) |
| 0.0 | 0.0 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
| 0.0 | 0.2 | GO:0046219 | serotonin biosynthetic process(GO:0042427) indole-containing compound biosynthetic process(GO:0042435) indolalkylamine biosynthetic process(GO:0046219) |
| 0.0 | 0.2 | GO:0006543 | glutamine catabolic process(GO:0006543) |
| 0.0 | 0.2 | GO:0035754 | B cell chemotaxis(GO:0035754) |
| 0.0 | 0.7 | GO:0071476 | hypotonic response(GO:0006971) cellular hypotonic response(GO:0071476) |
| 0.0 | 3.7 | GO:0046425 | regulation of JAK-STAT cascade(GO:0046425) regulation of STAT cascade(GO:1904892) |
| 0.0 | 0.8 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
| 0.0 | 0.6 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
| 0.0 | 0.8 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
| 0.0 | 0.1 | GO:0070670 | response to interleukin-4(GO:0070670) |
| 0.0 | 0.1 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
| 0.0 | 0.9 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
| 0.0 | 0.1 | GO:0098881 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 0.0 | 0.3 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 0.0 | 0.2 | GO:0072287 | metanephric distal tubule morphogenesis(GO:0072287) |
| 0.0 | 0.2 | GO:0001188 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 0.0 | 0.2 | GO:0042822 | pyridoxal phosphate metabolic process(GO:0042822) |
| 0.0 | 0.1 | GO:0019835 | cytolysis(GO:0019835) |
| 0.0 | 0.1 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
| 0.0 | 0.1 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
| 0.0 | 0.4 | GO:0042448 | progesterone metabolic process(GO:0042448) |
| 0.0 | 0.3 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
| 0.0 | 0.5 | GO:1900409 | positive regulation of cellular response to oxidative stress(GO:1900409) |
| 0.0 | 0.2 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
| 0.0 | 0.2 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
| 0.0 | 0.2 | GO:0000915 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 0.0 | 0.5 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
| 0.0 | 0.3 | GO:0016926 | protein desumoylation(GO:0016926) |
| 0.0 | 0.2 | GO:0050993 | dimethylallyl diphosphate biosynthetic process(GO:0050992) dimethylallyl diphosphate metabolic process(GO:0050993) |
| 0.0 | 0.9 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
| 0.0 | 5.4 | GO:0006334 | nucleosome assembly(GO:0006334) |
| 0.0 | 0.3 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
| 0.0 | 1.7 | GO:2000816 | negative regulation of mitotic sister chromatid separation(GO:2000816) |
| 0.0 | 4.0 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
| 0.0 | 0.1 | GO:0000303 | response to superoxide(GO:0000303) |
| 0.0 | 0.6 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
| 0.0 | 0.2 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
| 0.0 | 0.2 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.0 | 1.3 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
| 0.0 | 0.1 | GO:0045014 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 0.0 | 0.4 | GO:1902563 | regulation of neutrophil degranulation(GO:0043313) regulation of neutrophil activation(GO:1902563) |
| 0.0 | 0.5 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
| 0.0 | 0.4 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
| 0.0 | 3.9 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
| 0.0 | 0.1 | GO:0010446 | response to alkaline pH(GO:0010446) |
| 0.0 | 0.4 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.0 | 0.2 | GO:0070417 | cellular response to cold(GO:0070417) |
| 0.0 | 0.3 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
| 0.0 | 0.2 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.0 | 0.4 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
| 0.0 | 0.5 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
| 0.0 | 0.2 | GO:0045785 | positive regulation of cell adhesion(GO:0045785) |
| 0.0 | 0.4 | GO:0021978 | telencephalon regionalization(GO:0021978) |
| 0.0 | 0.3 | GO:0070572 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
| 0.0 | 0.5 | GO:0010002 | cardioblast differentiation(GO:0010002) |
| 0.0 | 0.1 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
| 0.0 | 0.2 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
| 0.0 | 0.2 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
| 0.0 | 0.1 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.0 | 0.1 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
| 0.0 | 0.7 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
| 0.0 | 1.0 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
| 0.0 | 0.1 | GO:0007296 | vitellogenesis(GO:0007296) |
| 0.0 | 0.2 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.0 | 1.2 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
| 0.0 | 0.3 | GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
| 0.0 | 0.8 | GO:0045332 | phospholipid translocation(GO:0045332) |
| 0.0 | 1.6 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
| 0.0 | 0.4 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.0 | 0.4 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 0.0 | 1.0 | GO:0042417 | dopamine metabolic process(GO:0042417) |
| 0.0 | 0.3 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.0 | 0.2 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
| 0.0 | 0.1 | GO:0006837 | serotonin transport(GO:0006837) |
| 0.0 | 0.3 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.0 | 0.1 | GO:0090649 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
| 0.0 | 0.2 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
| 0.0 | 0.2 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
| 0.0 | 0.2 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.0 | 0.1 | GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
| 0.0 | 0.2 | GO:1902969 | mitotic DNA replication(GO:1902969) |
| 0.0 | 0.1 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) negative regulation of integrin biosynthetic process(GO:0045720) |
| 0.0 | 0.2 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 0.0 | 0.3 | GO:0048266 | behavioral response to pain(GO:0048266) |
| 0.0 | 1.4 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
| 0.0 | 0.9 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.0 | 0.4 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 0.0 | 0.2 | GO:0051272 | positive regulation of cellular component movement(GO:0051272) |
| 0.0 | 0.5 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
| 0.0 | 0.2 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.0 | 0.6 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.0 | 0.1 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
| 0.0 | 0.1 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
| 0.0 | 1.1 | GO:0006270 | DNA replication initiation(GO:0006270) |
| 0.0 | 0.6 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
| 0.0 | 0.2 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
| 0.0 | 0.2 | GO:0010165 | response to X-ray(GO:0010165) |
| 0.0 | 0.1 | GO:0035690 | cellular response to drug(GO:0035690) |
| 0.0 | 0.0 | GO:0071554 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
| 0.0 | 0.1 | GO:0045208 | MAPK phosphatase export from nucleus(GO:0045208) MAPK phosphatase export from nucleus, leptomycin B sensitive(GO:0045209) |
| 0.0 | 2.1 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.0 | 0.1 | GO:0031063 | regulation of histone deacetylation(GO:0031063) |
| 0.0 | 0.2 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
| 0.0 | 0.3 | GO:0006868 | glutamine transport(GO:0006868) |
| 0.0 | 0.0 | GO:0032328 | alanine transport(GO:0032328) |
| 0.0 | 0.1 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
| 0.0 | 0.0 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 0.0 | 0.2 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.0 | 0.2 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
| 0.0 | 0.4 | GO:0008053 | mitochondrial fusion(GO:0008053) |
| 0.0 | 0.1 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
| 0.0 | 0.3 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
| 0.0 | 0.1 | GO:1904814 | regulation of protein localization to chromosome, telomeric region(GO:1904814) |
| 0.0 | 0.3 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.0 | 0.2 | GO:0010863 | positive regulation of phospholipase C activity(GO:0010863) |
| 0.0 | 0.2 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 0.0 | 0.2 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.0 | 0.2 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
| 0.0 | 0.1 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
| 0.0 | 0.2 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
| 0.0 | 0.2 | GO:0072143 | renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) |
| 0.0 | 0.1 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.0 | 0.5 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.0 | 0.1 | GO:0031644 | regulation of neurological system process(GO:0031644) |
| 0.0 | 0.4 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
| 0.0 | 0.1 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
| 0.0 | 0.1 | GO:0060023 | soft palate development(GO:0060023) |
| 0.0 | 0.1 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
| 0.0 | 0.1 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
| 0.0 | 0.1 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
| 0.0 | 0.2 | GO:2000109 | regulation of macrophage apoptotic process(GO:2000109) |
| 0.0 | 0.3 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
| 0.0 | 0.0 | GO:0001510 | RNA methylation(GO:0001510) |
| 0.0 | 0.1 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 0.0 | 0.4 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
| 0.0 | 0.1 | GO:0061386 | closure of optic fissure(GO:0061386) |
| 0.0 | 0.4 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
| 0.0 | 0.2 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.0 | 0.1 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
| 0.0 | 0.1 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
| 0.0 | 0.1 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
| 0.0 | 0.2 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.0 | 0.4 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.0 | 0.6 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
| 0.0 | 0.1 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
| 0.0 | 0.1 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
| 0.0 | 0.3 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.0 | 0.1 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.0 | 0.1 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
| 0.0 | 0.5 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
| 0.0 | 0.2 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.0 | 0.4 | GO:0042982 | amyloid precursor protein metabolic process(GO:0042982) |
| 0.0 | 0.2 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
| 0.0 | 0.2 | GO:0000023 | maltose metabolic process(GO:0000023) |
| 0.0 | 0.2 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
| 0.0 | 0.2 | GO:0046931 | pore complex assembly(GO:0046931) |
| 0.0 | 0.0 | GO:0031642 | negative regulation of myelination(GO:0031642) |
| 0.0 | 1.0 | GO:0002763 | positive regulation of myeloid leukocyte differentiation(GO:0002763) |
| 0.0 | 0.1 | GO:0070266 | necroptotic process(GO:0070266) |
| 0.0 | 0.1 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.0 | 0.5 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.0 | 0.1 | GO:1904253 | positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
| 0.0 | 0.2 | GO:0032098 | regulation of appetite(GO:0032098) |
| 0.0 | 0.2 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
| 0.0 | 0.1 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.0 | 0.3 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
| 0.0 | 0.0 | GO:1990418 | response to insulin-like growth factor stimulus(GO:1990418) |
| 0.0 | 0.1 | GO:0060021 | palate development(GO:0060021) |
| 0.0 | 0.2 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.0 | 0.1 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
| 0.0 | 0.0 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
| 0.0 | 0.3 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
| 0.0 | 0.3 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
| 0.0 | 0.1 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.0 | 0.4 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.0 | 0.1 | GO:0051647 | nucleus localization(GO:0051647) |
| 0.0 | 0.2 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
| 0.0 | 0.0 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
| 0.0 | 0.0 | GO:0002215 | defense response to nematode(GO:0002215) |
| 0.0 | 0.2 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.0 | 0.1 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
| 0.0 | 0.6 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
| 0.0 | 0.3 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 0.0 | 0.1 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.0 | 0.5 | GO:0010447 | response to acidic pH(GO:0010447) |
| 0.0 | 0.2 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 0.0 | 0.0 | GO:0032801 | receptor catabolic process(GO:0032801) |
| 0.0 | 0.1 | GO:0044805 | late nucleophagy(GO:0044805) |
| 0.0 | 0.1 | GO:0003351 | epithelial cilium movement(GO:0003351) |
| 0.0 | 0.1 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) negative regulation of cardiac muscle contraction(GO:0055118) |
| 0.0 | 1.8 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
| 0.0 | 0.3 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
| 0.0 | 0.2 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
| 0.0 | 0.2 | GO:0009629 | response to gravity(GO:0009629) |
| 0.0 | 0.2 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
| 0.0 | 0.5 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
| 0.0 | 0.1 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 0.0 | 0.3 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.0 | 0.3 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
| 0.0 | 0.6 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
| 0.0 | 0.1 | GO:0089700 | protein kinase D signaling(GO:0089700) |
| 0.0 | 5.6 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
| 0.0 | 0.1 | GO:0050927 | positive regulation of positive chemotaxis(GO:0050927) |
| 0.0 | 0.0 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
| 0.0 | 0.3 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
| 0.0 | 0.3 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
| 0.0 | 0.4 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.0 | 0.1 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
| 0.0 | 0.1 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 0.0 | 0.0 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
| 0.0 | 0.1 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.0 | 0.1 | GO:0032776 | DNA methylation on cytosine(GO:0032776) |
| 0.0 | 0.4 | GO:0007140 | male meiosis(GO:0007140) |
| 0.0 | 0.3 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.0 | 0.2 | GO:1903147 | negative regulation of macromitophagy(GO:1901525) negative regulation of mitophagy(GO:1903147) |
| 0.0 | 0.0 | GO:0007567 | parturition(GO:0007567) maternal process involved in parturition(GO:0060137) |
| 0.0 | 0.1 | GO:0097398 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.0 | 0.2 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
| 0.0 | 0.3 | GO:2000113 | negative regulation of cellular macromolecule biosynthetic process(GO:2000113) |
| 0.0 | 0.4 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
| 0.0 | 0.2 | GO:0031053 | primary miRNA processing(GO:0031053) |
| 0.0 | 0.3 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
| 0.0 | 0.4 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
| 0.0 | 0.1 | GO:1990785 | response to water-immersion restraint stress(GO:1990785) |
| 0.0 | 0.2 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
| 0.0 | 0.3 | GO:0001569 | patterning of blood vessels(GO:0001569) |
| 0.0 | 0.1 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
| 0.0 | 0.6 | GO:0030101 | natural killer cell activation(GO:0030101) |
| 0.0 | 0.6 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
| 0.0 | 0.1 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.0 | 0.8 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
| 0.0 | 0.1 | GO:0010587 | miRNA catabolic process(GO:0010587) |
| 0.0 | 0.1 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
| 0.0 | 0.0 | GO:0015748 | organophosphate ester transport(GO:0015748) |
| 0.0 | 0.1 | GO:0048749 | compound eye development(GO:0048749) |
| 0.0 | 0.0 | GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent(GO:0002479) |
| 0.0 | 0.1 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
| 0.0 | 9.1 | GO:0048232 | spermatogenesis(GO:0007283) male gamete generation(GO:0048232) |
| 0.0 | 1.9 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
| 0.0 | 0.1 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
| 0.0 | 0.1 | GO:0016322 | neuron remodeling(GO:0016322) |
| 0.0 | 0.1 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
| 0.0 | 0.2 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
| 0.0 | 0.2 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
| 0.0 | 0.1 | GO:0001964 | startle response(GO:0001964) |
| 0.0 | 0.1 | GO:0040013 | negative regulation of locomotion(GO:0040013) |
| 0.0 | 0.2 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 0.0 | 0.1 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.0 | 0.3 | GO:0016574 | histone ubiquitination(GO:0016574) |
| 0.0 | 0.1 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.0 | 0.1 | GO:0007398 | ectoderm development(GO:0007398) |
| 0.0 | 0.1 | GO:0017157 | regulation of exocytosis(GO:0017157) |
| 0.0 | 0.3 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.0 | 0.1 | GO:1900368 | regulation of RNA interference(GO:1900368) |
| 0.0 | 0.1 | GO:0016572 | histone phosphorylation(GO:0016572) |
| 0.0 | 0.3 | GO:0035666 | TRIF-dependent toll-like receptor signaling pathway(GO:0035666) |
| 0.0 | 0.1 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
| 0.0 | 0.2 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.0 | 0.1 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.0 | 1.5 | GO:0065004 | protein-DNA complex assembly(GO:0065004) |
| 0.0 | 0.1 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.0 | 0.3 | GO:0002181 | cytoplasmic translation(GO:0002181) |
| 0.0 | 0.0 | GO:0014038 | regulation of Schwann cell differentiation(GO:0014038) positive regulation of Schwann cell differentiation(GO:0014040) |
| 0.0 | 0.1 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.0 | 0.0 | GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter(GO:0072364) |
| 0.0 | 0.1 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
| 0.0 | 0.1 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
| 0.0 | 0.2 | GO:2000780 | negative regulation of double-strand break repair(GO:2000780) |
| 0.0 | 0.3 | GO:0006298 | mismatch repair(GO:0006298) |
| 0.0 | 0.1 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
| 0.0 | 0.1 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
| 0.0 | 0.0 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
| 0.0 | 0.1 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
| 0.0 | 0.1 | GO:0003018 | vascular process in circulatory system(GO:0003018) |
| 0.0 | 0.0 | GO:1901976 | regulation of cell cycle checkpoint(GO:1901976) |
| 0.0 | 0.1 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
| 0.0 | 0.1 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) semicircular canal development(GO:0060872) |
| 0.0 | 0.2 | GO:0035878 | nail development(GO:0035878) |
| 0.0 | 0.2 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
| 0.0 | 0.1 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
| 0.0 | 0.1 | GO:0002070 | epithelial cell maturation(GO:0002070) |
| 0.0 | 0.1 | GO:0051126 | negative regulation of actin nucleation(GO:0051126) |
| 0.0 | 0.0 | GO:0001759 | organ induction(GO:0001759) |
| 0.0 | 0.1 | GO:0003190 | atrioventricular valve formation(GO:0003190) |
| 0.0 | 0.0 | GO:0002562 | somatic diversification of immune receptors via germline recombination within a single locus(GO:0002562) somatic cell DNA recombination(GO:0016444) |
| 0.0 | 0.1 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.0 | 0.2 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.0 | 0.2 | GO:0046949 | fatty-acyl-CoA biosynthetic process(GO:0046949) |
| 0.0 | 0.3 | GO:0016577 | histone demethylation(GO:0016577) |
| 0.0 | 1.3 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.0 | 0.1 | GO:0046078 | dUMP metabolic process(GO:0046078) |
| 0.0 | 0.1 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
| 0.0 | 0.0 | GO:0001172 | transcription, RNA-templated(GO:0001172) |
| 0.0 | 0.2 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
| 0.0 | 0.8 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
| 0.0 | 0.0 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
| 0.0 | 0.1 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.0 | 0.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.0 | 0.1 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
| 0.0 | 0.0 | GO:0070922 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) small RNA loading onto RISC(GO:0070922) |
| 0.0 | 0.0 | GO:0071028 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
| 0.0 | 0.3 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.0 | 0.0 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
| 0.0 | 0.6 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 0.0 | 1.0 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
| 0.0 | 0.3 | GO:0006376 | mRNA splice site selection(GO:0006376) |
| 0.0 | 0.1 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 0.0 | 0.1 | GO:0044804 | nucleophagy(GO:0044804) |
| 0.0 | 0.4 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
| 0.0 | 0.2 | GO:0043966 | histone H3 acetylation(GO:0043966) |
| 0.0 | 0.0 | GO:0014744 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of muscle adaptation(GO:0014744) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 0.0 | 0.0 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
| 0.0 | 0.4 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.0 | 0.1 | GO:0042908 | xenobiotic transport(GO:0042908) |
| 0.0 | 0.1 | GO:0032196 | transposition(GO:0032196) |
| 0.0 | 0.2 | GO:0045806 | negative regulation of endocytosis(GO:0045806) |
| 0.0 | 0.1 | GO:0090494 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
| 0.0 | 0.0 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.0 | 0.1 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
| 0.0 | 0.0 | GO:0044108 | cellular alcohol metabolic process(GO:0044107) cellular alcohol biosynthetic process(GO:0044108) |
| 0.0 | 0.0 | GO:0036451 | cap mRNA methylation(GO:0036451) |
| 0.0 | 0.0 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
| 0.0 | 0.1 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.0 | 0.0 | GO:0030279 | negative regulation of ossification(GO:0030279) |
| 0.0 | 0.1 | GO:0035063 | nuclear speck organization(GO:0035063) |
| 0.0 | 0.3 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
| 0.0 | 0.1 | GO:0000212 | meiotic spindle organization(GO:0000212) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.8 | 2.4 | GO:0098844 | postsynaptic endocytic zone membrane(GO:0098844) |
| 0.7 | 38.2 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
| 0.6 | 8.4 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
| 0.5 | 1.5 | GO:1990015 | mesaxon(GO:0097453) ensheathing process(GO:1990015) |
| 0.4 | 2.6 | GO:0097441 | basilar dendrite(GO:0097441) |
| 0.4 | 5.1 | GO:0060203 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
| 0.4 | 1.6 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
| 0.4 | 1.2 | GO:0033150 | cytoskeletal calyx(GO:0033150) |
| 0.4 | 1.6 | GO:0019815 | B cell receptor complex(GO:0019815) |
| 0.4 | 2.6 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
| 0.3 | 5.5 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
| 0.3 | 1.2 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
| 0.3 | 0.3 | GO:0033011 | perinuclear theca(GO:0033011) |
| 0.3 | 3.0 | GO:0032010 | phagolysosome(GO:0032010) |
| 0.3 | 1.5 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
| 0.3 | 1.5 | GO:0036398 | TCR signalosome(GO:0036398) |
| 0.3 | 3.8 | GO:0044327 | dendritic spine head(GO:0044327) |
| 0.3 | 2.0 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
| 0.3 | 2.2 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
| 0.3 | 7.3 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 0.3 | 0.8 | GO:0032783 | ELL-EAF complex(GO:0032783) |
| 0.3 | 3.3 | GO:0036157 | outer dynein arm(GO:0036157) |
| 0.2 | 1.7 | GO:0044194 | cytolytic granule(GO:0044194) |
| 0.2 | 0.5 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.2 | 1.3 | GO:1990769 | proximal neuron projection(GO:1990769) |
| 0.2 | 2.9 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
| 0.2 | 2.7 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
| 0.2 | 1.2 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
| 0.2 | 0.8 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
| 0.2 | 2.2 | GO:0071546 | pi-body(GO:0071546) |
| 0.2 | 1.2 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
| 0.2 | 1.8 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
| 0.2 | 0.8 | GO:0005873 | plus-end kinesin complex(GO:0005873) |
| 0.2 | 0.4 | GO:0012506 | vesicle membrane(GO:0012506) |
| 0.2 | 2.0 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
| 0.2 | 0.5 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
| 0.2 | 0.5 | GO:0097636 | intrinsic component of autophagosome membrane(GO:0097636) integral component of autophagosome membrane(GO:0097637) |
| 0.2 | 10.3 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.2 | 0.8 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
| 0.2 | 2.9 | GO:0033010 | paranodal junction(GO:0033010) |
| 0.2 | 3.0 | GO:0033093 | Weibel-Palade body(GO:0033093) |
| 0.2 | 1.4 | GO:0035976 | AP1 complex(GO:0035976) |
| 0.2 | 0.6 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
| 0.2 | 0.5 | GO:0072517 | viral factory(GO:0039713) cytoplasmic viral factory(GO:0039714) host cell viral assembly compartment(GO:0072517) |
| 0.2 | 0.2 | GO:0060200 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
| 0.2 | 0.5 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
| 0.1 | 0.7 | GO:1990031 | pinceau fiber(GO:1990031) |
| 0.1 | 0.4 | GO:0005638 | lamin filament(GO:0005638) |
| 0.1 | 0.4 | GO:0097450 | astrocyte end-foot(GO:0097450) |
| 0.1 | 3.0 | GO:0042613 | MHC class II protein complex(GO:0042613) |
| 0.1 | 0.6 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
| 0.1 | 1.5 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.1 | 4.2 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
| 0.1 | 1.5 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 0.1 | 3.7 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.1 | 0.5 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
| 0.1 | 0.5 | GO:0072534 | perineuronal net(GO:0072534) |
| 0.1 | 1.7 | GO:0030314 | junctional membrane complex(GO:0030314) |
| 0.1 | 1.0 | GO:0032133 | chromosome passenger complex(GO:0032133) |
| 0.1 | 0.6 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
| 0.1 | 0.8 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 0.1 | 0.9 | GO:0098536 | deuterosome(GO:0098536) |
| 0.1 | 4.3 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.1 | 0.1 | GO:0000811 | GINS complex(GO:0000811) |
| 0.1 | 1.0 | GO:0005955 | calcineurin complex(GO:0005955) |
| 0.1 | 1.1 | GO:0042025 | host cell nucleus(GO:0042025) |
| 0.1 | 0.6 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
| 0.1 | 14.4 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.1 | 4.6 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
| 0.1 | 0.8 | GO:0097427 | microtubule bundle(GO:0097427) |
| 0.1 | 0.9 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
| 0.1 | 0.5 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
| 0.1 | 0.7 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
| 0.1 | 3.4 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.1 | 2.8 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
| 0.1 | 0.4 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
| 0.1 | 0.6 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
| 0.1 | 1.4 | GO:0097524 | sperm plasma membrane(GO:0097524) |
| 0.1 | 0.3 | GO:0070081 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
| 0.1 | 1.2 | GO:0060198 | clathrin-sculpted vesicle(GO:0060198) |
| 0.1 | 0.8 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
| 0.1 | 0.8 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.1 | 0.8 | GO:0098984 | neuron to neuron synapse(GO:0098984) |
| 0.1 | 0.9 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
| 0.1 | 2.8 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
| 0.1 | 1.0 | GO:0000801 | central element(GO:0000801) |
| 0.1 | 0.3 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
| 0.1 | 0.3 | GO:0043196 | varicosity(GO:0043196) |
| 0.1 | 5.1 | GO:0055038 | recycling endosome membrane(GO:0055038) |
| 0.1 | 11.3 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 0.1 | 2.2 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.1 | 0.5 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
| 0.1 | 0.9 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.1 | 4.8 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.1 | 0.3 | GO:0034678 | integrin alpha8-beta1 complex(GO:0034678) |
| 0.1 | 1.4 | GO:0000788 | nuclear nucleosome(GO:0000788) |
| 0.1 | 0.3 | GO:0032997 | Fc receptor complex(GO:0032997) Fc-epsilon receptor I complex(GO:0032998) |
| 0.1 | 0.4 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
| 0.1 | 1.1 | GO:0035102 | PRC1 complex(GO:0035102) |
| 0.1 | 3.3 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 0.1 | 0.9 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
| 0.1 | 0.3 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
| 0.1 | 0.3 | GO:1990742 | microvesicle(GO:1990742) |
| 0.1 | 0.5 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
| 0.1 | 0.8 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 0.1 | 2.7 | GO:0060076 | excitatory synapse(GO:0060076) |
| 0.1 | 0.7 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
| 0.1 | 0.6 | GO:0042825 | TAP complex(GO:0042825) |
| 0.1 | 1.2 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
| 0.1 | 0.6 | GO:0030061 | mitochondrial crista(GO:0030061) |
| 0.1 | 0.5 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
| 0.1 | 4.8 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.1 | 28.9 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 0.1 | 1.4 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.1 | 17.2 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
| 0.1 | 0.4 | GO:0071547 | piP-body(GO:0071547) |
| 0.1 | 0.3 | GO:0016342 | catenin complex(GO:0016342) |
| 0.1 | 0.5 | GO:0000799 | nuclear condensin complex(GO:0000799) |
| 0.1 | 0.8 | GO:0061574 | ASAP complex(GO:0061574) |
| 0.1 | 1.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.1 | 0.2 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
| 0.1 | 0.3 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
| 0.1 | 0.5 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 0.1 | 0.4 | GO:0001741 | XY body(GO:0001741) |
| 0.1 | 4.4 | GO:0000786 | nucleosome(GO:0000786) |
| 0.1 | 0.1 | GO:0044308 | axonal spine(GO:0044308) |
| 0.1 | 0.2 | GO:1990812 | growth cone filopodium(GO:1990812) |
| 0.1 | 1.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
| 0.1 | 0.8 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
| 0.1 | 0.2 | GO:0009346 | citrate lyase complex(GO:0009346) |
| 0.1 | 0.2 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
| 0.1 | 0.9 | GO:0001940 | male pronucleus(GO:0001940) |
| 0.1 | 2.4 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
| 0.1 | 5.7 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
| 0.1 | 0.9 | GO:0033269 | internode region of axon(GO:0033269) |
| 0.1 | 1.2 | GO:0032838 | cell projection cytoplasm(GO:0032838) |
| 0.1 | 8.1 | GO:0005901 | caveola(GO:0005901) |
| 0.1 | 1.6 | GO:0008021 | synaptic vesicle(GO:0008021) |
| 0.1 | 8.1 | GO:0036126 | sperm flagellum(GO:0036126) |
| 0.1 | 0.3 | GO:0097165 | nuclear stress granule(GO:0097165) |
| 0.1 | 0.4 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
| 0.1 | 0.8 | GO:0071438 | invadopodium membrane(GO:0071438) |
| 0.1 | 0.2 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
| 0.1 | 1.8 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
| 0.1 | 0.2 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 0.1 | 1.1 | GO:0061702 | inflammasome complex(GO:0061702) |
| 0.1 | 0.1 | GO:0005683 | U7 snRNP(GO:0005683) |
| 0.1 | 1.6 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.1 | 0.2 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
| 0.1 | 0.4 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 0.1 | 1.6 | GO:0005719 | nuclear euchromatin(GO:0005719) |
| 0.1 | 0.3 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
| 0.1 | 0.7 | GO:0045495 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
| 0.1 | 1.1 | GO:0042555 | MCM complex(GO:0042555) |
| 0.1 | 1.0 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 0.1 | 0.7 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 0.1 | 0.6 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
| 0.1 | 8.2 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
| 0.1 | 0.3 | GO:0071564 | npBAF complex(GO:0071564) |
| 0.1 | 6.2 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
| 0.1 | 0.6 | GO:1990909 | Wnt signalosome(GO:1990909) |
| 0.1 | 0.4 | GO:0042382 | paraspeckles(GO:0042382) |
| 0.1 | 1.4 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
| 0.1 | 0.8 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
| 0.1 | 0.2 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
| 0.1 | 0.6 | GO:0031298 | replication fork protection complex(GO:0031298) |
| 0.1 | 0.9 | GO:0060091 | kinocilium(GO:0060091) |
| 0.1 | 0.8 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.1 | 0.2 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
| 0.1 | 0.4 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
| 0.1 | 0.7 | GO:0042589 | zymogen granule membrane(GO:0042589) |
| 0.1 | 0.4 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
| 0.1 | 1.5 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
| 0.1 | 0.5 | GO:0090576 | transcription factor TFIIIC complex(GO:0000127) RNA polymerase III transcription factor complex(GO:0090576) |
| 0.1 | 0.8 | GO:0070187 | telosome(GO:0070187) |
| 0.0 | 2.2 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
| 0.0 | 1.0 | GO:0031105 | septin complex(GO:0031105) |
| 0.0 | 0.3 | GO:0036128 | CatSper complex(GO:0036128) |
| 0.0 | 0.8 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.0 | 0.4 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
| 0.0 | 0.4 | GO:0070545 | PeBoW complex(GO:0070545) |
| 0.0 | 0.3 | GO:0036021 | endolysosome lumen(GO:0036021) |
| 0.0 | 0.2 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 0.0 | 0.2 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
| 0.0 | 0.2 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
| 0.0 | 0.7 | GO:0034709 | methylosome(GO:0034709) |
| 0.0 | 0.7 | GO:0033268 | node of Ranvier(GO:0033268) |
| 0.0 | 0.2 | GO:0002133 | polycystin complex(GO:0002133) |
| 0.0 | 0.6 | GO:0000322 | storage vacuole(GO:0000322) |
| 0.0 | 0.9 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
| 0.0 | 0.3 | GO:0030175 | filopodium(GO:0030175) |
| 0.0 | 0.2 | GO:0002177 | manchette(GO:0002177) |
| 0.0 | 0.2 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
| 0.0 | 0.3 | GO:0097452 | GAIT complex(GO:0097452) |
| 0.0 | 1.6 | GO:0000776 | kinetochore(GO:0000776) |
| 0.0 | 0.1 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
| 0.0 | 0.4 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 0.0 | 0.4 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.0 | 0.3 | GO:0071203 | WASH complex(GO:0071203) |
| 0.0 | 0.1 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
| 0.0 | 0.2 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
| 0.0 | 2.7 | GO:0005637 | nuclear inner membrane(GO:0005637) |
| 0.0 | 0.2 | GO:0071797 | LUBAC complex(GO:0071797) |
| 0.0 | 0.3 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
| 0.0 | 4.3 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
| 0.0 | 5.6 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
| 0.0 | 0.2 | GO:0016938 | kinesin I complex(GO:0016938) |
| 0.0 | 0.8 | GO:0031932 | TORC2 complex(GO:0031932) |
| 0.0 | 0.3 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 0.0 | 1.4 | GO:0000795 | synaptonemal complex(GO:0000795) |
| 0.0 | 0.2 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
| 0.0 | 0.1 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.0 | 0.9 | GO:0031519 | PcG protein complex(GO:0031519) |
| 0.0 | 0.8 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
| 0.0 | 3.6 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
| 0.0 | 0.1 | GO:0000229 | cytoplasmic chromosome(GO:0000229) |
| 0.0 | 2.2 | GO:0031594 | neuromuscular junction(GO:0031594) |
| 0.0 | 0.2 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
| 0.0 | 0.4 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
| 0.0 | 0.2 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
| 0.0 | 0.6 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
| 0.0 | 2.6 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
| 0.0 | 0.4 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
| 0.0 | 0.1 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
| 0.0 | 0.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
| 0.0 | 0.2 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
| 0.0 | 0.4 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 0.0 | 0.9 | GO:0044291 | cell-cell contact zone(GO:0044291) |
| 0.0 | 0.4 | GO:0097440 | apical dendrite(GO:0097440) |
| 0.0 | 0.2 | GO:0044232 | organelle membrane contact site(GO:0044232) |
| 0.0 | 0.2 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
| 0.0 | 0.2 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.0 | 11.2 | GO:0000790 | nuclear chromatin(GO:0000790) |
| 0.0 | 0.0 | GO:0016939 | kinesin II complex(GO:0016939) |
| 0.0 | 0.4 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.0 | 0.4 | GO:0042405 | nuclear inclusion body(GO:0042405) |
| 0.0 | 0.3 | GO:0016013 | syntrophin complex(GO:0016013) |
| 0.0 | 0.4 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.0 | 0.4 | GO:0043034 | costamere(GO:0043034) |
| 0.0 | 0.2 | GO:0030891 | VCB complex(GO:0030891) |
| 0.0 | 0.2 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
| 0.0 | 0.2 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 0.0 | 0.3 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
| 0.0 | 0.3 | GO:0098574 | cytoplasmic side of lysosomal membrane(GO:0098574) |
| 0.0 | 3.6 | GO:0016605 | PML body(GO:0016605) |
| 0.0 | 0.2 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 0.0 | 0.1 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 0.0 | 0.1 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
| 0.0 | 0.3 | GO:0070652 | HAUS complex(GO:0070652) |
| 0.0 | 0.8 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
| 0.0 | 0.1 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.0 | 0.1 | GO:1990876 | cytoplasmic side of nuclear pore(GO:1990876) |
| 0.0 | 0.1 | GO:0017102 | methionyl glutamyl tRNA synthetase complex(GO:0017102) |
| 0.0 | 0.4 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.0 | 0.6 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.0 | 0.5 | GO:0035145 | exon-exon junction complex(GO:0035145) |
| 0.0 | 0.2 | GO:0016272 | prefoldin complex(GO:0016272) |
| 0.0 | 0.1 | GO:1990745 | EARP complex(GO:1990745) |
| 0.0 | 0.3 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
| 0.0 | 0.1 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
| 0.0 | 0.4 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
| 0.0 | 1.0 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.0 | 0.2 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.0 | 0.1 | GO:0097422 | tubular endosome(GO:0097422) |
| 0.0 | 0.1 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
| 0.0 | 0.2 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
| 0.0 | 1.0 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.0 | 0.3 | GO:0016461 | unconventional myosin complex(GO:0016461) |
| 0.0 | 0.5 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.0 | 0.5 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
| 0.0 | 3.0 | GO:0005814 | centriole(GO:0005814) |
| 0.0 | 0.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
| 0.0 | 0.1 | GO:0097431 | mitotic spindle pole(GO:0097431) |
| 0.0 | 1.0 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.0 | 0.1 | GO:0070522 | nucleotide-excision repair factor 1 complex(GO:0000110) ERCC4-ERCC1 complex(GO:0070522) |
| 0.0 | 0.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
| 0.0 | 0.2 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
| 0.0 | 0.2 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 0.0 | 0.0 | GO:0030681 | ribonuclease MRP complex(GO:0000172) multimeric ribonuclease P complex(GO:0030681) |
| 0.0 | 0.2 | GO:0019908 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
| 0.0 | 0.2 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 0.0 | 0.1 | GO:0000439 | core TFIIH complex(GO:0000439) |
| 0.0 | 1.3 | GO:0042734 | presynaptic membrane(GO:0042734) |
| 0.0 | 0.1 | GO:0045293 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
| 0.0 | 0.4 | GO:0031904 | endosome lumen(GO:0031904) |
| 0.0 | 0.2 | GO:0032585 | multivesicular body membrane(GO:0032585) |
| 0.0 | 0.1 | GO:0030686 | 90S preribosome(GO:0030686) |
| 0.0 | 0.5 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 0.0 | 0.1 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
| 0.0 | 1.6 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.0 | 0.1 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
| 0.0 | 0.2 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
| 0.0 | 0.1 | GO:0030286 | dynein complex(GO:0030286) |
| 0.0 | 0.1 | GO:0030673 | axolemma(GO:0030673) |
| 0.0 | 0.0 | GO:0089701 | U2AF(GO:0089701) |
| 0.0 | 0.2 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
| 0.0 | 1.5 | GO:0030141 | secretory granule(GO:0030141) |
| 0.0 | 0.4 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.0 | 0.3 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
| 0.0 | 0.1 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
| 0.0 | 0.2 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.0 | 0.4 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.0 | 0.2 | GO:0000242 | pericentriolar material(GO:0000242) |
| 0.0 | 0.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 0.0 | 0.1 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
| 0.0 | 0.1 | GO:0032009 | early phagosome(GO:0032009) |
| 0.0 | 0.1 | GO:0005827 | polar microtubule(GO:0005827) |
| 0.0 | 0.6 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
| 0.0 | 0.6 | GO:0015030 | Cajal body(GO:0015030) |
| 0.0 | 0.1 | GO:0032021 | NELF complex(GO:0032021) |
| 0.0 | 0.3 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
| 0.0 | 0.0 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
| 0.0 | 0.1 | GO:0043194 | axon initial segment(GO:0043194) |
| 0.0 | 0.3 | GO:0005684 | U2-type spliceosomal complex(GO:0005684) |
| 0.0 | 0.1 | GO:0000974 | Prp19 complex(GO:0000974) |
| 0.0 | 0.2 | GO:0034518 | RNA cap binding complex(GO:0034518) |
| 0.0 | 0.1 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 0.0 | 0.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
| 0.0 | 0.1 | GO:0005594 | collagen type IX trimer(GO:0005594) |
| 0.0 | 5.0 | GO:0016607 | nuclear speck(GO:0016607) |
| 0.0 | 1.6 | GO:0031901 | early endosome membrane(GO:0031901) |
| 0.0 | 1.0 | GO:0043679 | axon terminus(GO:0043679) |
| 0.0 | 0.0 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 0.0 | 0.1 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
| 0.0 | 2.2 | GO:0045211 | postsynaptic membrane(GO:0045211) |
| 0.0 | 0.2 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.0 | 0.2 | GO:0032040 | small-subunit processome(GO:0032040) |
| 0.0 | 0.1 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.1 | 8.5 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
| 0.8 | 2.4 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) |
| 0.8 | 3.9 | GO:0019976 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
| 0.8 | 3.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
| 0.7 | 1.5 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
| 0.7 | 3.6 | GO:0004914 | interleukin-5 receptor activity(GO:0004914) |
| 0.7 | 1.4 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
| 0.6 | 3.2 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
| 0.6 | 3.1 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 0.6 | 5.4 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
| 0.6 | 38.9 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 0.6 | 1.8 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
| 0.6 | 3.6 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
| 0.6 | 4.0 | GO:0001515 | opioid peptide activity(GO:0001515) |
| 0.5 | 4.8 | GO:0042610 | CD8 receptor binding(GO:0042610) |
| 0.5 | 1.6 | GO:0005174 | CD40 receptor binding(GO:0005174) |
| 0.5 | 2.6 | GO:0015254 | glycerol channel activity(GO:0015254) |
| 0.5 | 1.5 | GO:0031859 | platelet activating factor receptor binding(GO:0031859) |
| 0.5 | 1.9 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
| 0.5 | 1.4 | GO:0031877 | somatostatin receptor binding(GO:0031877) |
| 0.4 | 1.3 | GO:0031768 | ghrelin receptor binding(GO:0031768) |
| 0.4 | 1.3 | GO:0015633 | zinc transporting ATPase activity(GO:0015633) |
| 0.4 | 1.2 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
| 0.4 | 1.6 | GO:0031811 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
| 0.4 | 3.9 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 0.4 | 1.1 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 0.4 | 1.1 | GO:0070119 | ciliary neurotrophic factor binding(GO:0070119) |
| 0.4 | 1.1 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
| 0.4 | 5.7 | GO:0019864 | IgG binding(GO:0019864) |
| 0.4 | 0.4 | GO:0052593 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
| 0.3 | 74.4 | GO:0003823 | antigen binding(GO:0003823) |
| 0.3 | 1.7 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
| 0.3 | 4.0 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 0.3 | 1.7 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
| 0.3 | 0.3 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
| 0.3 | 2.3 | GO:0032396 | inhibitory MHC class I receptor activity(GO:0032396) |
| 0.3 | 1.0 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
| 0.3 | 2.7 | GO:0019863 | IgE binding(GO:0019863) |
| 0.3 | 0.9 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
| 0.3 | 0.9 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
| 0.3 | 1.5 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
| 0.3 | 1.5 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
| 0.3 | 0.3 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
| 0.3 | 2.5 | GO:1903136 | cuprous ion binding(GO:1903136) |
| 0.3 | 0.3 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
| 0.3 | 1.1 | GO:0098808 | mRNA cap binding(GO:0098808) |
| 0.3 | 3.5 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.3 | 0.3 | GO:0005499 | vitamin D binding(GO:0005499) |
| 0.3 | 1.3 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
| 0.3 | 2.4 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
| 0.3 | 1.6 | GO:0004918 | interleukin-8 receptor activity(GO:0004918) |
| 0.3 | 1.8 | GO:0033691 | sialic acid binding(GO:0033691) |
| 0.2 | 1.0 | GO:0010348 | lithium:proton antiporter activity(GO:0010348) |
| 0.2 | 0.7 | GO:0038131 | neuregulin receptor activity(GO:0038131) |
| 0.2 | 3.6 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
| 0.2 | 2.1 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
| 0.2 | 2.6 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 0.2 | 0.7 | GO:0004397 | histidine ammonia-lyase activity(GO:0004397) |
| 0.2 | 0.2 | GO:0001012 | RNA polymerase II regulatory region DNA binding(GO:0001012) |
| 0.2 | 1.6 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
| 0.2 | 1.1 | GO:0034584 | piRNA binding(GO:0034584) |
| 0.2 | 0.7 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.2 | 1.3 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 0.2 | 0.9 | GO:0032406 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
| 0.2 | 0.6 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
| 0.2 | 1.3 | GO:0030492 | hemoglobin binding(GO:0030492) |
| 0.2 | 4.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.2 | 3.8 | GO:0003796 | lysozyme activity(GO:0003796) |
| 0.2 | 2.1 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
| 0.2 | 0.6 | GO:0045518 | interleukin-22 receptor binding(GO:0045518) |
| 0.2 | 0.6 | GO:0098782 | mechanically-gated potassium channel activity(GO:0098782) |
| 0.2 | 0.8 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
| 0.2 | 0.6 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
| 0.2 | 1.2 | GO:0042608 | T cell receptor binding(GO:0042608) |
| 0.2 | 0.8 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 0.2 | 1.0 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
| 0.2 | 0.6 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
| 0.2 | 0.8 | GO:0050528 | acyloxyacyl hydrolase activity(GO:0050528) |
| 0.2 | 0.8 | GO:0015265 | urea channel activity(GO:0015265) |
| 0.2 | 0.2 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
| 0.2 | 0.7 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
| 0.2 | 2.0 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
| 0.2 | 1.4 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
| 0.2 | 0.5 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
| 0.2 | 2.9 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.2 | 3.4 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
| 0.2 | 0.5 | GO:0052856 | NADHX epimerase activity(GO:0052856) NADPHX epimerase activity(GO:0052857) |
| 0.2 | 0.5 | GO:0031531 | thyrotropin-releasing hormone receptor binding(GO:0031531) |
| 0.2 | 1.0 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
| 0.2 | 1.2 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
| 0.2 | 0.5 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
| 0.2 | 4.8 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.2 | 0.7 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
| 0.2 | 1.5 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
| 0.2 | 0.8 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 0.2 | 0.6 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
| 0.2 | 0.3 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
| 0.2 | 0.5 | GO:0005148 | prolactin receptor binding(GO:0005148) |
| 0.2 | 0.5 | GO:0071723 | lipopeptide binding(GO:0071723) |
| 0.2 | 0.5 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
| 0.2 | 0.5 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
| 0.2 | 2.3 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 0.1 | 0.6 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) phosphofructokinase activity(GO:0008443) |
| 0.1 | 1.2 | GO:1990459 | transferrin receptor binding(GO:1990459) |
| 0.1 | 1.6 | GO:0019237 | centromeric DNA binding(GO:0019237) |
| 0.1 | 0.9 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
| 0.1 | 0.6 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
| 0.1 | 1.9 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
| 0.1 | 1.4 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
| 0.1 | 0.4 | GO:0004817 | cysteine-tRNA ligase activity(GO:0004817) |
| 0.1 | 0.7 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
| 0.1 | 1.1 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
| 0.1 | 1.1 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
| 0.1 | 0.9 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
| 0.1 | 3.7 | GO:0045295 | gamma-catenin binding(GO:0045295) |
| 0.1 | 0.7 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
| 0.1 | 1.6 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 0.1 | 1.8 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
| 0.1 | 0.6 | GO:0038047 | beta-endorphin receptor activity(GO:0004979) morphine receptor activity(GO:0038047) |
| 0.1 | 2.7 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
| 0.1 | 1.5 | GO:0046870 | cadmium ion binding(GO:0046870) |
| 0.1 | 0.8 | GO:0017161 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
| 0.1 | 0.3 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
| 0.1 | 4.4 | GO:0043495 | protein anchor(GO:0043495) |
| 0.1 | 5.6 | GO:0035586 | purinergic receptor activity(GO:0035586) |
| 0.1 | 0.9 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
| 0.1 | 2.7 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
| 0.1 | 0.4 | GO:0004423 | iduronate-2-sulfatase activity(GO:0004423) |
| 0.1 | 0.9 | GO:0004713 | protein tyrosine kinase activity(GO:0004713) |
| 0.1 | 4.0 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
| 0.1 | 0.4 | GO:0019779 | Atg12 activating enzyme activity(GO:0019778) Atg8 activating enzyme activity(GO:0019779) |
| 0.1 | 0.9 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
| 0.1 | 0.5 | GO:0070644 | vitamin D response element binding(GO:0070644) |
| 0.1 | 0.5 | GO:0001026 | TFIIIB-type transcription factor activity(GO:0001026) |
| 0.1 | 1.8 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.1 | 0.5 | GO:0005042 | netrin receptor activity(GO:0005042) |
| 0.1 | 0.5 | GO:0004802 | transketolase activity(GO:0004802) |
| 0.1 | 0.5 | GO:0004998 | transferrin receptor activity(GO:0004998) |
| 0.1 | 2.3 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.1 | 0.9 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
| 0.1 | 1.2 | GO:0042835 | BRE binding(GO:0042835) |
| 0.1 | 0.8 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
| 0.1 | 0.9 | GO:1990763 | arrestin family protein binding(GO:1990763) |
| 0.1 | 0.2 | GO:0035276 | ethanol binding(GO:0035276) |
| 0.1 | 1.0 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
| 0.1 | 1.3 | GO:0010851 | cyclase regulator activity(GO:0010851) |
| 0.1 | 0.8 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 0.1 | 1.6 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.1 | 4.7 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
| 0.1 | 1.4 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.1 | 0.5 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 0.1 | 0.3 | GO:0004532 | exoribonuclease activity(GO:0004532) |
| 0.1 | 2.7 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
| 0.1 | 1.1 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
| 0.1 | 2.4 | GO:0003680 | AT DNA binding(GO:0003680) |
| 0.1 | 0.5 | GO:0004796 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
| 0.1 | 0.6 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
| 0.1 | 0.4 | GO:0004310 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
| 0.1 | 0.2 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
| 0.1 | 0.3 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
| 0.1 | 1.5 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
| 0.1 | 1.0 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
| 0.1 | 0.5 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
| 0.1 | 0.3 | GO:0047783 | steroid 11-beta-monooxygenase activity(GO:0004507) corticosterone 18-monooxygenase activity(GO:0047783) |
| 0.1 | 10.6 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
| 0.1 | 1.2 | GO:0042834 | peptidoglycan binding(GO:0042834) |
| 0.1 | 1.0 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.1 | 1.5 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
| 0.1 | 2.0 | GO:0042923 | neuropeptide binding(GO:0042923) |
| 0.1 | 1.6 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 0.1 | 0.3 | GO:0050135 | NAD(P)+ nucleosidase activity(GO:0050135) |
| 0.1 | 1.8 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.1 | 1.6 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
| 0.1 | 2.6 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
| 0.1 | 4.6 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.1 | 1.0 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
| 0.1 | 0.4 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
| 0.1 | 0.2 | GO:0015172 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
| 0.1 | 1.3 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 0.1 | 1.1 | GO:0050544 | arachidonic acid binding(GO:0050544) |
| 0.1 | 0.3 | GO:0052894 | norspermine:oxygen oxidoreductase activity(GO:0052894) N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity(GO:0052895) |
| 0.1 | 0.9 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
| 0.1 | 0.9 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
| 0.1 | 2.3 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.1 | 0.6 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 0.1 | 0.4 | GO:0071209 | U7 snRNA binding(GO:0071209) |
| 0.1 | 4.3 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.1 | 2.6 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.1 | 1.0 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
| 0.1 | 0.4 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.1 | 2.0 | GO:0005522 | profilin binding(GO:0005522) |
| 0.1 | 0.3 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
| 0.1 | 0.5 | GO:0051120 | hepoxilin A3 synthase activity(GO:0051120) |
| 0.1 | 2.9 | GO:0008009 | chemokine activity(GO:0008009) |
| 0.1 | 0.4 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
| 0.1 | 0.3 | GO:0004818 | glutamate-tRNA ligase activity(GO:0004818) |
| 0.1 | 0.7 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.1 | 0.5 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
| 0.1 | 2.4 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
| 0.1 | 0.8 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
| 0.1 | 2.8 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.1 | 0.3 | GO:0016833 | hydroxymethylglutaryl-CoA lyase activity(GO:0004419) oxo-acid-lyase activity(GO:0016833) |
| 0.1 | 3.2 | GO:0045503 | dynein light chain binding(GO:0045503) |
| 0.1 | 0.4 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
| 0.1 | 0.4 | GO:0032052 | bile acid binding(GO:0032052) |
| 0.1 | 0.8 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.1 | 3.9 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 0.1 | 2.0 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
| 0.1 | 0.3 | GO:1990404 | protein ADP-ribosylase activity(GO:1990404) |
| 0.1 | 0.8 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
| 0.1 | 1.9 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 0.1 | 1.0 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 0.1 | 0.3 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
| 0.1 | 1.1 | GO:0004630 | phospholipase D activity(GO:0004630) |
| 0.1 | 1.0 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 0.1 | 0.3 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
| 0.1 | 0.4 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
| 0.1 | 0.6 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
| 0.1 | 0.6 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
| 0.1 | 0.7 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
| 0.1 | 1.0 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.1 | 0.4 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
| 0.1 | 0.6 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
| 0.1 | 0.2 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
| 0.1 | 0.6 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
| 0.1 | 2.1 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
| 0.1 | 0.4 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
| 0.1 | 0.5 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
| 0.1 | 2.7 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
| 0.1 | 0.9 | GO:0016015 | morphogen activity(GO:0016015) |
| 0.1 | 1.8 | GO:0001223 | transcription coactivator binding(GO:0001223) |
| 0.1 | 0.5 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 0.1 | 0.2 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
| 0.1 | 2.7 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.1 | 3.0 | GO:0042287 | MHC protein binding(GO:0042287) |
| 0.1 | 0.1 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
| 0.1 | 0.4 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
| 0.1 | 1.2 | GO:0039706 | co-receptor binding(GO:0039706) |
| 0.1 | 1.4 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.1 | 0.7 | GO:0043515 | kinetochore binding(GO:0043515) |
| 0.1 | 0.9 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
| 0.1 | 0.7 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 0.1 | 0.2 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
| 0.1 | 0.2 | GO:0003878 | ATP citrate synthase activity(GO:0003878) |
| 0.1 | 1.3 | GO:0051018 | protein kinase A binding(GO:0051018) |
| 0.1 | 2.8 | GO:0070840 | dynein complex binding(GO:0070840) |
| 0.1 | 1.0 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
| 0.1 | 0.3 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
| 0.1 | 2.8 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.1 | 0.4 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
| 0.1 | 2.1 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
| 0.1 | 0.7 | GO:0031490 | chromatin DNA binding(GO:0031490) |
| 0.1 | 0.4 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
| 0.1 | 1.4 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 0.1 | 0.5 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 0.1 | 0.2 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
| 0.1 | 0.7 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
| 0.1 | 0.8 | GO:0051378 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
| 0.1 | 0.3 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 0.1 | 0.2 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
| 0.1 | 1.2 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
| 0.1 | 0.3 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 0.1 | 0.3 | GO:0003947 | (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity(GO:0003947) |
| 0.1 | 0.1 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
| 0.1 | 0.4 | GO:0031849 | olfactory receptor binding(GO:0031849) |
| 0.1 | 2.1 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.1 | 3.0 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.1 | 0.5 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 0.1 | 0.2 | GO:0031685 | adenosine receptor binding(GO:0031685) |
| 0.1 | 0.6 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 0.1 | 0.2 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 0.1 | 0.8 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
| 0.1 | 0.7 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 0.1 | 2.1 | GO:0008327 | methyl-CpG binding(GO:0008327) |
| 0.1 | 0.2 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
| 0.1 | 0.4 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
| 0.1 | 0.3 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
| 0.1 | 0.2 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 0.1 | 1.1 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
| 0.1 | 1.5 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.1 | 0.5 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
| 0.1 | 0.3 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
| 0.1 | 0.3 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
| 0.1 | 0.8 | GO:0016791 | phosphatase activity(GO:0016791) |
| 0.1 | 0.3 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.1 | 0.3 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
| 0.1 | 1.4 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
| 0.1 | 0.2 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
| 0.1 | 0.9 | GO:0000150 | recombinase activity(GO:0000150) |
| 0.1 | 0.2 | GO:0047280 | nicotinamide phosphoribosyltransferase activity(GO:0047280) |
| 0.1 | 0.4 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
| 0.1 | 0.4 | GO:1990254 | keratin filament binding(GO:1990254) |
| 0.1 | 0.7 | GO:0031369 | translation initiation factor binding(GO:0031369) |
| 0.1 | 0.3 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
| 0.1 | 0.2 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
| 0.1 | 0.6 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
| 0.1 | 1.2 | GO:0032183 | SUMO binding(GO:0032183) |
| 0.1 | 1.6 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.1 | 0.3 | GO:0017147 | Wnt-protein binding(GO:0017147) |
| 0.1 | 0.4 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
| 0.1 | 0.2 | GO:0035034 | histone acetyltransferase regulator activity(GO:0035034) |
| 0.1 | 1.4 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.1 | 0.4 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
| 0.1 | 1.1 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 0.1 | 1.0 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 0.1 | 0.4 | GO:0019003 | GDP binding(GO:0019003) |
| 0.0 | 0.4 | GO:0003917 | DNA topoisomerase activity(GO:0003916) DNA topoisomerase type I activity(GO:0003917) |
| 0.0 | 1.7 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.0 | 0.5 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.0 | 0.6 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
| 0.0 | 0.1 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
| 0.0 | 12.1 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.0 | 0.4 | GO:0005158 | insulin receptor binding(GO:0005158) |
| 0.0 | 0.2 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
| 0.0 | 0.3 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 0.0 | 0.4 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
| 0.0 | 0.3 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
| 0.0 | 1.1 | GO:0008494 | translation activator activity(GO:0008494) |
| 0.0 | 0.1 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
| 0.0 | 2.8 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
| 0.0 | 1.3 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.0 | 0.2 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
| 0.0 | 2.1 | GO:0004385 | guanylate kinase activity(GO:0004385) |
| 0.0 | 1.3 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
| 0.0 | 2.2 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 0.0 | 0.4 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
| 0.0 | 0.2 | GO:0004510 | tryptophan 5-monooxygenase activity(GO:0004510) |
| 0.0 | 0.2 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
| 0.0 | 0.2 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
| 0.0 | 0.7 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 0.0 | 0.6 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
| 0.0 | 0.8 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
| 0.0 | 1.2 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
| 0.0 | 0.7 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
| 0.0 | 0.5 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 0.0 | 0.2 | GO:0008267 | poly-glutamine tract binding(GO:0008267) |
| 0.0 | 1.1 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.0 | 0.2 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
| 0.0 | 2.0 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.0 | 0.3 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
| 0.0 | 0.2 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
| 0.0 | 0.7 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
| 0.0 | 2.4 | GO:0070412 | R-SMAD binding(GO:0070412) |
| 0.0 | 0.5 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.0 | 0.1 | GO:0004960 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
| 0.0 | 0.7 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 0.0 | 0.2 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
| 0.0 | 0.2 | GO:0004452 | isopentenyl-diphosphate delta-isomerase activity(GO:0004452) |
| 0.0 | 0.4 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
| 0.0 | 0.3 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 0.0 | 1.7 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.0 | 0.2 | GO:0043566 | structure-specific DNA binding(GO:0043566) |
| 0.0 | 0.3 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
| 0.0 | 0.5 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.0 | 0.2 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
| 0.0 | 0.4 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
| 0.0 | 1.7 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.0 | 1.8 | GO:0005549 | odorant binding(GO:0005549) |
| 0.0 | 1.1 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
| 0.0 | 0.2 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.0 | 0.3 | GO:0099589 | serotonin receptor activity(GO:0099589) |
| 0.0 | 0.2 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
| 0.0 | 0.1 | GO:0033867 | Fas-activated serine/threonine kinase activity(GO:0033867) |
| 0.0 | 0.6 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
| 0.0 | 1.5 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.0 | 0.1 | GO:0050254 | rhodopsin kinase activity(GO:0050254) |
| 0.0 | 0.5 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
| 0.0 | 0.1 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
| 0.0 | 0.9 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
| 0.0 | 0.4 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
| 0.0 | 0.1 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
| 0.0 | 0.3 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
| 0.0 | 0.3 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 0.0 | 4.2 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 0.0 | 0.6 | GO:0004672 | protein kinase activity(GO:0004672) |
| 0.0 | 1.5 | GO:0036002 | pre-mRNA binding(GO:0036002) |
| 0.0 | 0.7 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
| 0.0 | 0.1 | GO:0034736 | sterol O-acyltransferase activity(GO:0004772) cholesterol O-acyltransferase activity(GO:0034736) |
| 0.0 | 0.2 | GO:0099583 | postsynaptic neurotransmitter receptor activity(GO:0098960) neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
| 0.0 | 0.2 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
| 0.0 | 1.1 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.0 | 1.3 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.0 | 0.1 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
| 0.0 | 0.1 | GO:0015039 | ferredoxin-NADP+ reductase activity(GO:0004324) NADPH-adrenodoxin reductase activity(GO:0015039) oxidoreductase activity, acting on iron-sulfur proteins as donors(GO:0016730) oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor(GO:0016731) |
| 0.0 | 0.7 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
| 0.0 | 0.3 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
| 0.0 | 0.2 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
| 0.0 | 0.2 | GO:0019534 | toxin transporter activity(GO:0019534) |
| 0.0 | 0.1 | GO:0031432 | titin binding(GO:0031432) |
| 0.0 | 0.3 | GO:0035174 | histone serine kinase activity(GO:0035174) |
| 0.0 | 0.7 | GO:0051400 | BH domain binding(GO:0051400) |
| 0.0 | 0.3 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
| 0.0 | 0.2 | GO:1902444 | riboflavin binding(GO:1902444) |
| 0.0 | 0.5 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
| 0.0 | 2.1 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
| 0.0 | 0.3 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
| 0.0 | 0.1 | GO:0004968 | gonadotropin-releasing hormone receptor activity(GO:0004968) |
| 0.0 | 1.0 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
| 0.0 | 0.1 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.0 | 0.3 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
| 0.0 | 0.2 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.0 | 0.1 | GO:0004766 | spermidine synthase activity(GO:0004766) |
| 0.0 | 2.0 | GO:0019894 | kinesin binding(GO:0019894) |
| 0.0 | 0.2 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
| 0.0 | 0.3 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
| 0.0 | 1.4 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
| 0.0 | 1.2 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 0.0 | 0.2 | GO:0042166 | acetylcholine binding(GO:0042166) |
| 0.0 | 0.3 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.0 | 0.2 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
| 0.0 | 2.0 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
| 0.0 | 0.7 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
| 0.0 | 0.2 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
| 0.0 | 0.1 | GO:0005334 | norepinephrine:sodium symporter activity(GO:0005334) |
| 0.0 | 0.5 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
| 0.0 | 0.2 | GO:0070728 | leucine binding(GO:0070728) |
| 0.0 | 0.2 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
| 0.0 | 0.2 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) maltose alpha-glucosidase activity(GO:0032450) |
| 0.0 | 5.5 | GO:0005125 | cytokine activity(GO:0005125) |
| 0.0 | 0.1 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
| 0.0 | 0.7 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 0.0 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
| 0.0 | 0.1 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
| 0.0 | 0.2 | GO:0004620 | phospholipase activity(GO:0004620) |
| 0.0 | 1.2 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.0 | 0.6 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
| 0.0 | 0.1 | GO:0016517 | interleukin-12 receptor activity(GO:0016517) |
| 0.0 | 0.1 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
| 0.0 | 0.3 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
| 0.0 | 0.3 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
| 0.0 | 0.1 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) |
| 0.0 | 0.1 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
| 0.0 | 0.2 | GO:0033613 | activating transcription factor binding(GO:0033613) |
| 0.0 | 0.1 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
| 0.0 | 0.1 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
| 0.0 | 0.2 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
| 0.0 | 0.1 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
| 0.0 | 0.1 | GO:0038132 | neuregulin binding(GO:0038132) |
| 0.0 | 0.2 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
| 0.0 | 0.4 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
| 0.0 | 0.2 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
| 0.0 | 0.3 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.0 | 2.5 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.0 | 0.4 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.0 | 0.5 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.0 | 1.0 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.0 | 0.1 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
| 0.0 | 0.1 | GO:0090631 | pre-miRNA transporter activity(GO:0090631) |
| 0.0 | 0.7 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
| 0.0 | 0.2 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
| 0.0 | 0.2 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 0.0 | 0.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
| 0.0 | 0.1 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
| 0.0 | 0.2 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
| 0.0 | 0.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
| 0.0 | 0.1 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
| 0.0 | 0.2 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
| 0.0 | 0.7 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
| 0.0 | 0.5 | GO:0070034 | telomerase RNA binding(GO:0070034) |
| 0.0 | 0.2 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
| 0.0 | 0.1 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 0.0 | 0.3 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
| 0.0 | 0.6 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
| 0.0 | 0.2 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.0 | 0.5 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.0 | 0.3 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 0.0 | 0.8 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.0 | 0.3 | GO:0036310 | annealing helicase activity(GO:0036310) |
| 0.0 | 0.1 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
| 0.0 | 0.1 | GO:0031208 | POZ domain binding(GO:0031208) |
| 0.0 | 0.5 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 0.0 | 0.1 | GO:0005234 | ionotropic glutamate receptor activity(GO:0004970) extracellular-glutamate-gated ion channel activity(GO:0005234) |
| 0.0 | 0.2 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
| 0.0 | 0.4 | GO:0004568 | chitinase activity(GO:0004568) |
| 0.0 | 0.3 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.0 | 0.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
| 0.0 | 0.8 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
| 0.0 | 0.1 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
| 0.0 | 0.8 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
| 0.0 | 0.3 | GO:0001222 | transcription corepressor binding(GO:0001222) |
| 0.0 | 0.1 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.0 | 0.4 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.0 | 0.4 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.0 | 0.2 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
| 0.0 | 0.1 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 0.0 | 0.2 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
| 0.0 | 0.2 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
| 0.0 | 7.5 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.0 | 0.2 | GO:0017048 | Rho GTPase binding(GO:0017048) |
| 0.0 | 0.4 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.0 | 3.7 | GO:0004984 | olfactory receptor activity(GO:0004984) |
| 0.0 | 0.1 | GO:0030621 | U4 snRNA binding(GO:0030621) |
| 0.0 | 0.1 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
| 0.0 | 0.2 | GO:0005112 | Notch binding(GO:0005112) |
| 0.0 | 0.1 | GO:0031386 | protein tag(GO:0031386) |
| 0.0 | 0.1 | GO:0048156 | tau protein binding(GO:0048156) |
| 0.0 | 0.5 | GO:0032452 | histone demethylase activity(GO:0032452) |
| 0.0 | 0.1 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
| 0.0 | 0.5 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
| 0.0 | 1.5 | GO:0042826 | histone deacetylase binding(GO:0042826) |
| 0.0 | 1.0 | GO:0070063 | RNA polymerase binding(GO:0070063) |
| 0.0 | 0.1 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 0.0 | 0.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
| 0.0 | 0.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
| 0.0 | 1.6 | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) |
| 0.0 | 0.4 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.0 | 0.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 0.0 | 0.0 | GO:0001032 | RNA polymerase III type 3 promoter DNA binding(GO:0001032) |
| 0.0 | 0.0 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
| 0.0 | 0.8 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
| 0.0 | 0.1 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 0.0 | 0.0 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
| 0.0 | 1.2 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
| 0.0 | 0.2 | GO:0004697 | protein kinase C activity(GO:0004697) |
| 0.0 | 0.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
| 0.0 | 0.1 | GO:0016803 | ether hydrolase activity(GO:0016803) |
| 0.0 | 0.1 | GO:0008301 | DNA binding, bending(GO:0008301) |
| 0.0 | 0.6 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.0 | 0.0 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
| 0.0 | 0.0 | GO:0043813 | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) |
| 0.0 | 0.2 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 0.0 | 0.8 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
| 0.0 | 0.3 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.0 | 0.0 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
| 0.0 | 0.1 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
| 0.0 | 0.5 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
| 0.0 | 0.0 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
| 0.0 | 0.3 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
| 0.0 | 0.1 | GO:0008955 | peptidoglycan glycosyltransferase activity(GO:0008955) |
| 0.0 | 0.1 | GO:0048019 | receptor antagonist activity(GO:0048019) |
| 0.0 | 0.3 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.0 | 0.1 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
| 0.0 | 0.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 0.0 | 1.1 | GO:0019905 | syntaxin binding(GO:0019905) |
| 0.0 | 0.4 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
| 0.0 | 0.1 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 0.0 | 0.0 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
| 0.0 | 0.0 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
| 0.0 | 0.3 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.0 | 5.1 | GO:0030695 | GTPase regulator activity(GO:0030695) |
| 0.0 | 0.0 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.0 | 0.2 | GO:0001540 | beta-amyloid binding(GO:0001540) |
| 0.0 | 0.0 | GO:0035197 | siRNA binding(GO:0035197) |
| 0.0 | 0.0 | GO:0005047 | signal recognition particle binding(GO:0005047) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.5 | 14.9 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
| 0.3 | 15.7 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
| 0.2 | 8.9 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.2 | 8.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
| 0.2 | 20.6 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
| 0.2 | 11.1 | PID BCR 5PATHWAY | BCR signaling pathway |
| 0.1 | 7.9 | PID IL2 1PATHWAY | IL2-mediated signaling events |
| 0.1 | 0.1 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
| 0.1 | 3.4 | PID IL23 PATHWAY | IL23-mediated signaling events |
| 0.1 | 3.3 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
| 0.1 | 3.5 | PID IL5 PATHWAY | IL5-mediated signaling events |
| 0.1 | 0.5 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
| 0.1 | 2.7 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.1 | 5.0 | PID REELIN PATHWAY | Reelin signaling pathway |
| 0.1 | 5.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
| 0.1 | 3.0 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
| 0.1 | 8.8 | PID AURORA B PATHWAY | Aurora B signaling |
| 0.1 | 1.8 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.1 | 1.2 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
| 0.1 | 0.3 | SIG CHEMOTAXIS | Genes related to chemotaxis |
| 0.1 | 1.6 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 0.1 | 3.4 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.1 | 3.4 | PID CD40 PATHWAY | CD40/CD40L signaling |
| 0.1 | 2.9 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
| 0.1 | 4.9 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
| 0.1 | 3.1 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.1 | 5.9 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
| 0.1 | 2.6 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.1 | 3.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.1 | 2.6 | PID IL12 2PATHWAY | IL12-mediated signaling events |
| 0.1 | 0.3 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
| 0.1 | 4.1 | PID IL4 2PATHWAY | IL4-mediated signaling events |
| 0.1 | 1.4 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
| 0.1 | 5.2 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.1 | 0.3 | ST STAT3 PATHWAY | STAT3 Pathway |
| 0.1 | 3.9 | PID ATR PATHWAY | ATR signaling pathway |
| 0.1 | 1.4 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
| 0.1 | 0.6 | ST G ALPHA I PATHWAY | G alpha i Pathway |
| 0.1 | 5.6 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
| 0.1 | 6.8 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
| 0.0 | 2.1 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.0 | 2.9 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.0 | 1.0 | PID ALK2 PATHWAY | ALK2 signaling events |
| 0.0 | 1.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 0.0 | 3.0 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.0 | 0.4 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 0.0 | 0.8 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
| 0.0 | 0.9 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
| 0.0 | 1.3 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
| 0.0 | 1.4 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
| 0.0 | 0.1 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 0.0 | 0.3 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 0.0 | 1.0 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
| 0.0 | 0.9 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
| 0.0 | 0.7 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.0 | 1.6 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.0 | 0.2 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.0 | 0.9 | PID AURORA A PATHWAY | Aurora A signaling |
| 0.0 | 0.7 | PID MYC PATHWAY | C-MYC pathway |
| 0.0 | 1.1 | PID ARF6 PATHWAY | Arf6 signaling events |
| 0.0 | 2.0 | PID P53 REGULATION PATHWAY | p53 pathway |
| 0.0 | 1.4 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
| 0.0 | 0.4 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.0 | 0.8 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
| 0.0 | 0.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
| 0.0 | 0.4 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.0 | 0.6 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
| 0.0 | 0.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.0 | 3.2 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
| 0.0 | 0.8 | PID AP1 PATHWAY | AP-1 transcription factor network |
| 0.0 | 0.4 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.0 | 0.6 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.0 | 0.3 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.0 | 0.2 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 0.0 | 0.4 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.5 | 13.6 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
| 0.4 | 13.6 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
| 0.3 | 6.4 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
| 0.3 | 2.1 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
| 0.2 | 0.2 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
| 0.2 | 18.7 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.2 | 11.3 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
| 0.2 | 23.7 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 0.2 | 1.4 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
| 0.2 | 6.8 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
| 0.2 | 1.3 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
| 0.2 | 3.2 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
| 0.2 | 2.5 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.2 | 1.4 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.2 | 2.3 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
| 0.2 | 6.0 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
| 0.2 | 5.0 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
| 0.1 | 2.6 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
| 0.1 | 3.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.1 | 1.2 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
| 0.1 | 6.3 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
| 0.1 | 6.3 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 0.1 | 21.4 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
| 0.1 | 0.5 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
| 0.1 | 2.1 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
| 0.1 | 4.3 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
| 0.1 | 7.6 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.1 | 4.4 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 0.1 | 0.4 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
| 0.1 | 2.2 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
| 0.1 | 0.4 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
| 0.1 | 4.4 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.1 | 8.9 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
| 0.1 | 1.5 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.1 | 1.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
| 0.1 | 1.2 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 0.1 | 0.4 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
| 0.1 | 0.7 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
| 0.1 | 4.3 | REACTOME KINESINS | Genes involved in Kinesins |
| 0.1 | 1.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
| 0.1 | 1.0 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
| 0.1 | 2.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.1 | 2.5 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.1 | 1.9 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.1 | 1.8 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
| 0.1 | 2.0 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.1 | 4.6 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
| 0.1 | 0.7 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
| 0.1 | 5.4 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
| 0.1 | 1.3 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
| 0.1 | 0.7 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
| 0.1 | 3.3 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.1 | 3.5 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
| 0.1 | 1.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.1 | 2.1 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
| 0.1 | 1.4 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
| 0.1 | 0.5 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.1 | 2.8 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
| 0.1 | 1.6 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
| 0.1 | 0.4 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
| 0.0 | 2.1 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
| 0.0 | 0.5 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
| 0.0 | 0.0 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
| 0.0 | 8.1 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
| 0.0 | 3.2 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.0 | 0.8 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
| 0.0 | 0.6 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
| 0.0 | 0.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
| 0.0 | 0.7 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
| 0.0 | 1.6 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
| 0.0 | 2.3 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
| 0.0 | 1.0 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
| 0.0 | 1.2 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
| 0.0 | 0.5 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
| 0.0 | 0.2 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
| 0.0 | 0.4 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
| 0.0 | 0.9 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 0.0 | 0.7 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
| 0.0 | 0.2 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
| 0.0 | 0.7 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 0.0 | 1.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
| 0.0 | 1.3 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 0.0 | 0.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.0 | 0.9 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 0.0 | 3.3 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
| 0.0 | 0.2 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
| 0.0 | 1.0 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.0 | 1.3 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
| 0.0 | 0.3 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.0 | 0.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
| 0.0 | 0.2 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
| 0.0 | 0.4 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
| 0.0 | 0.2 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
| 0.0 | 0.3 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
| 0.0 | 2.6 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
| 0.0 | 0.7 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
| 0.0 | 0.4 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.0 | 2.9 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.0 | 0.5 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
| 0.0 | 1.0 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
| 0.0 | 3.4 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
| 0.0 | 0.2 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
| 0.0 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
| 0.0 | 0.5 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
| 0.0 | 0.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.0 | 0.7 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
| 0.0 | 0.7 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
| 0.0 | 0.7 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
| 0.0 | 0.5 | REACTOME TRANSCRIPTION COUPLED NER TC NER | Genes involved in Transcription-coupled NER (TC-NER) |
| 0.0 | 0.9 | REACTOME CHROMOSOME MAINTENANCE | Genes involved in Chromosome Maintenance |
| 0.0 | 4.8 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
| 0.0 | 0.7 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.0 | 1.2 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
| 0.0 | 3.8 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.0 | 0.2 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
| 0.0 | 0.4 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
| 0.0 | 0.5 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
| 0.0 | 1.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
| 0.0 | 0.5 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
| 0.0 | 0.3 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.0 | 0.3 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
| 0.0 | 1.5 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
| 0.0 | 0.4 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
| 0.0 | 0.2 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.0 | 0.4 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
| 0.0 | 0.7 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 0.0 | 0.1 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
| 0.0 | 0.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.0 | 1.3 | REACTOME REGULATION OF MITOTIC CELL CYCLE | Genes involved in Regulation of mitotic cell cycle |
| 0.0 | 0.3 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |